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II. INTRODUCTION 
 
 
 
1. Introduction 
 
 
 
1.1 Scientific background of PTPIP51 
 
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) was discovered about 
ten years ago. Using the yeast two hybrid screening method, it was initially identified 
as an interaction partner of T-cell protein tyrosine phosphatase (TcPTP) and later, to 
a much higher extent, Protein tyrosine phosphatase 1B (PTP1B) (Stenzinger et al., 
2009). To reveal the function of PTPIP51 several studies dealt with its expression 
pattern and its interaction partners in different tissues and cell culture systems. 
PTPIP51 protein is expressed in epithelial cells of various organs. Highest evidence 
of PTPIP51 in epithelia can be found in skin where the expression of PTPIP51 is 
most likely associated with differentiation processes. The protein was also described 
in  ciliated  cells  of  the  trachea,  the  fallopian  tube  and  ependyma  of  the  brain 
(Stenzinger  et  al.,  2009).  Recently,  PTPIP51  was  detected  in  non-keratinized 
epithelia of the mouth. Furthermore it is expressed in neurons in the brain and 
several  brain  tumours.  In  brain  tissue,  the  expression  is  restricted  to  distinct 
functional nuclei, for example nucleus subthalamicus and nucleus paraventricularis. 
Additionally, PTPIP51 could be found in Purkinje cells of the cerebellum (Koch et al., 
2009b). 
 
Stenzinger et al. (2005) described a fast-fibre-type specific expression pattern of 
PTPIP51 in skeletal muscle, here being significantly associated to fast-contracting 
type-2a-fibres (Stenzinger et al., 2005). 
PTPIP51 is also expressed in male reproductive tissue, where it can be detected 
throughout the complete differentiation process, from the primary spermatocytes up 
to the spermatid stage (Stenzinger et al., 2009). In placenta, PTPIP51 is expressed 
in syncytiotrophoblast and cytotrophoblast layer from the first, second, and third 
trimesters (Stenzinger et al., 2009). Stenzinger et al. (2007) investigated the 
expression of PTPIP51 in liver tissue. The tissue featured PTPIP51 protein in non- 
parenchymal cells, namely Kupffer cells, stellate cells and natural killer cells. Despite 
that specific association with non-parenchymal cells, a subset of hepatocyte nuclei 
3 
INTRODUCTION  
 
 
 
 
 
and cholangiocytes of the bile  tract also expressed PTPIP51  (Stenzinger et al., 
 
2007). 
 
PTPIP51 also was seen in all investigated primary and secondary cell lines. Different 
studies revealed that PTPIP51 is expressed in a multitude of cell lines, such as 
glucagon-producing  cells  (INR1G9),  human  keratinocytes 
(HaCat), human placental cells (BeWo), acetylcholine- 
producing  cells  (NS20Y),  Jurkat  T-lymphoma  cells 
(Stenzinger et al. 2005) and human skeletal muscle cells 
(Barop et al. 2009) as well as in a mouse fibroblast cell line 
 
Fig. 1: PTPIP51 in 
proliferating 3T3 
mouse fibroblast 
 
(3T3)  (Fig.  1)  and  a  leukemia  cell  line  (HL60)  (Brobeil, 
personal communication). 
These observations gave basis for further functional studies. 
 
 
 
1.2 PTPIP51 in different cellular processes 
 
First studies indicated an involvement of PTPIP51 in differentiation processes, as the 
protein was solely expressed in suprabasal cells of the epidermis (Koch et al., 2008). 
Further experimental exploration was conducted by investigating human keratinocyte 
cell culture (HaCat cells). Several experiments revealed that PTPIP51 expression 
can be upregulated by stimulation with Epithelial Growth Factor (EGF) or 1,25OH2D3, 
two factors stimulating differentiation and inhibiting proliferation (Hashimoto, 2000; 
Stenzinger et al., 2009). Recently, a phosphorylation dependent activation of the 
MAPK pathway was proven by Brobeil et al. (2012). The MAPK pathway is important 
for proliferation and differentiation of cells. Activation of the MAPK pathway can be 
induced by several receptors like epithelial growth factor receptor (EGFR) (Petri  et 
al., 2011) or downstream by the receptor kinases. One possibility of such a 
downstream activation is the activation of raf-1. 14-3-3β is able to interact with raf-1 
and thus activate the MAPK pathway. PTPIP51 seems to play an important role in 
this interaction (Brobeil et al., 2012). 
Barop et al. (2009) investigated the expression of PTPIP51 during muscle cell 
differentiation. Proliferating myoblasts displayed low expression levels of both mRNA 
and protein. Induction of differentiation to myotubes led to a sharp increase in 
PTPIP51 expression. In differentiated multinuclear myotubes PTPIP51 expression 
was highest. Re-induction of proliferation again decreased the level of PTPIP51 
4 
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protein in the myotubes, so a differentiation dependent expression profile seems 
likely. 
Further experiments by Brobeil et al. (2010) described PTPIP51 expression in 
differentiated cells of the immune system. Bone marrow specimen, umbilical cord 
blood and peripheral venous blood were all positively tested for PTPIP51 expressing 
cells. Especially neutrophil granulocytes showed high PTPIP51 expression levels in 
all investigated samples. In human bone marrow specimen PTPIP51 could also be 
traced in myeloid precursor cells of neutrophils (Brobeil et al., 2010). 
 
 
Based on the observation of a nucleic localization and an increased expression in 
several types of cancer, experiments were conducted to investigate whether or not 
PTPIP51 is also involved in proliferation processes. PTPIP51 exhibits partial 
sequence homology with the microtubule-associated protein regulator of microtubule 
dynamics  1  (RMD-1).  Therefore,  PTPIP51  has  been  internalized  in  a  family  of 
proteins which are named regulator of microtubule dynamics (RMD), according to 
their assumed function. PTPIP51 is also called regulator of microtubule dynamics 3 
(RMD-3) (Oishi et al., 2007; Brobeil et al., 2011a). 
In vivo experiments associated PTPIP51 with the cell cycle. Important regulators of 
mitotic processes, CGI-99 and Nuf-2, were found to interact with PTPIP51 through a 
two-hybrid  screen  that  used  PTPIP51  as  bait  (Stenzinger  et  al.,  2009).  The 
interaction with CGI-99 hints towards an involvement of PTPIP51 in the regulation of 
polymerization of microtubules, whereas the interaction with Nuf-2 indicates a 
modulating function on the spindle apparatus (Brobeil et al., 2012). Therefore, 
PTPIP51 seems to be an important protein in proliferating cells, which is also shown 
by its expression in tumour tissue. 
 
 
Additionally,  PTPIP51  seems  to  be  involved  in  apoptosis.  Overexpression  of 
 
PTPIP51 in HEK293T and HeLa cells led to the induction of apoptosis (Lv et al., 
 
2006). Transfection of these cells with PTPIP51 led to a significant increase in the 
active caspase 3 and its substrate poly ADP ribose polymerase (Lv et al., 2006), two 
indicators of apoptosis. These findings were accompanied by a reduction of the 
mitochondrial membrane potential and cytochrome c release. 
5 
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1.3 PTPIP51 in cancer 
 
Studies on different kinds of cancer revealed an association of PTPIP51 with 
proliferating cells. 
In glioblastoma cells, PTPIP51 expression was significantly upregulated compared to 
healthy glial cells. The expression of PTPIP51 was linked to 14-3-3β expression and 
to the tumour grade (Petri et al., 2011). 
In  prostate  cancer,  PTPIP51  mRNA  levels  were  slightly  increased  compared  to 
benign prostate hyperplasia (Koch et al., 2009a). Furthermore, the gene promoter 
region of prostate cancer was unmethylated. In benign prostate hyperplasia, 70% of 
CpG-rich islands were methylated. 
Malignant melanoma cells displayed specific expression patterns of PTPIP51. The 
protein was also detected in peritumoural tissue. Koch et al. (2008) assumed that 
PTPIP51 might play a role in the development of keratinocyte tumours. 
Current data concerning PTPIP51 in cancer reveals an increased expression in 
several leukemia cells and in squamous cell carcinoma (SCC) of the oropharynx 
(Brobeil et al., 2010; Planz, personal communication) 
 
 
These observations of several different functions result in the question how this 
protein is capable of influencing oppositely directed signal pathways. 
 
 
 
 
2.  PTPIP51 - Gene, mRNA and protein 
 
 
 
2.1 PTPIP51 gene 
 
The gene of PTPIP51 is located on chromosome 15 (15q15.1, position 41,028,086- 
 
41,047,458), encompasses 13 exons and has a length of 19,373 base pairs (bp). Up 
to now, information about the gene and its regulation are rare. 
Three mechanisms for the regulation of PTPIP51 gene transcription have been 
described so far. 
Koch et al. (2009a) investigated the methylation status of the gene promoters and 
disclosed methylation dependence in PTPIP51 gene expression. In comparison to 
benign  prostate  hyperplasia,  the  PTPIP51  gene  is  hypomethylated  in  prostate 
cancer, whereas PTPIP51 protein expression is upregulated. Methylation of CpG-rich 
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islands associated with gene promoters leads to gene silencing through inhibition of 
binding sites for relevant transcription factors. Demethylation leads to the opposite 
effect: Cells display increased transcription and translation of demethylated genes 
(Ellis et al., 2009). In benign prostate hyperplasia, eighteen investigated CpG-rich 
regions are hypermethylated compared to their methylation status in prostate cancer 
(Koch et al., 2009a). 
Another regulatory mechanism for increasing PTPIP51 expression is the regulation 
by the cAMP responsive element binding protein (CREB). A CREB binding site on 
the PTPIP51 gene has been identified by recent database research (Brobeil et al., 
2011a). Several factors that are influenced by PTPIP51 seem to increase its 
expression by interaction with CREB, namely PKA and p90 ribosomal S6 kinase 
(p90RSK), leading to the regulation of the MAPK pathway (Zhang et al., 2005; 
Shaywitz and Greenberg, 1999; McCubrey et al., 2000). 
Roger et al. (2007) identified the ciliary neurotrophic factor (CNTF) to inhibit PTPIP51 
expression  during  retinal  differentiation.  CNTF  is  a  neuroprotective  factor  (De 
Almeida et al., 2001) that possibly protects the differentiating retina cells from the 
pro-apoptotic effects of PTPIP51 (Brobeil et al., 2011a) 
 
 
 
2.2. PTPIP51 mRNA 
 
PTPIP51 mRNA consists of 2251 basepairs (bp), distributed over 13 exons. Exon 1 
forms the untranslated 5’ region and is a noncoding exon. Protein synthesis ends at a 
triplet  on  exon  13  at  position  1596.  This  position  holds  a  stop-codon  related 
sequence (UAA) (Brobeil et al., 2011a). Initiation of translation starts at particular 
sequences, namely Kozak-sequences (GCCRCCaugG, whereas R stands for purine 
bases) (Kozak et al., 2005). AUG triplets mostly start Open Reading Frames (ORFs). 
Five ORFs have been identified so far. One of them is located upstream of the 
coding exons. This upORF is possibly able to regulate translation of PTPIP51, as 
observed in several other proteins (Kozak et al., 2005). As PTPIP51 holds different 
functions, an expression of different isoforms of the protein is assumed. Two different 
reasons for isoforms could be important for PTPIP51: leaky scanning and alternative 
splicing. Leaky scanning results in N-truncated isoforms (Kochetov 2008). Alternative 
splicing is a second possibility to explain isoforms. It is estimated that about 95-100% 
of pre-mRNAs from multi-exon-genes are alternatively spliced (Nilsen and Graveley 
2010). 
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2.3 PTPIP51 protein 
 
The full length form of human PTPIP51 consists of 470 amino acids with a molecular 
weight of 52,118 kDa. Calculations revealed several potential isoforms with different 
molecular weights (45 kDa, 38 kDa and 30 kDa). They display partially different 
expression patterns than the full length form. These isoforms are possibly generated 
through alternative splicing or leaky scanning, two mechanisms accounting for 
variations in protein length and weight. 
The full length protein possesses several domains that are important for its functions 
 
but lack in some of its isoforms (Fig. 2). 
 
 
 
 
 
 
 
 
Fig. 2: Domains and phosphorylation sites of PTPIP51 
S: Serine; Y: Tyrosine 
TMD: transmembrane domain; CR1 and CR2: Conserved region 1 and 2; CC: Coiled-coil 
domain; TPR: Tetratricopeptide repeat domain 
Numbers: amino acids 
 
 
 
 
The  N-terminal  transmembrane  domain  is  required  for  its  association  to 
mitochondria.  The  association  of  PTPIP51  to  mitochondria  seems  to  induce 
apoptosis as seen in HEK293T cells and HeLa cells (Lv et al. 2006). 
Conserved region 1 (CR1) and 2 (CR2) are two crucial domains of the protein. CR1, 
spanning amino acid (aa) 43 to aa 48 and CR2, spanning aa 146 to aa 154, are 
binding sites for 14-3-3β. Yu et al. (2008) indicated that, after deletion of one of the 
conserved regions, the other one alone is able to bind 14-3-3β and activate the 
MAPK pathway. These findings indicate that there might be more functions for these 
regions than only the MAPK pathway activation. 
PTPIP51 also possesses a coiled-coil domain, spanning aa 92 to aa 124. Such a 
coiled-coil domain indicates an involvement of the protein in vesicle trafficking in 
general and in hormone release in particular, as seen in hypothalamic neurons 
(Gillingham and Munro, 2003; Fotheringham et al. 1991; Koch et al. 2009b). Proteins 
INTRODUCTION 
8 
 
 
 
 
 
 
with coiled-coil domains are also important during mitosis. Nuf-2, for example, is a 
protein with a coiled-coil domain (Brobeil et al., 2011a). The interaction of Nuf-2 and 
PTPIP51 seems to be important during mitosis (Brobeil et al., 2012). 
A tetratricopeptide repeat (TPR) like domain at aa303 to aa447 also seems to be 
associated with the cell cycle (Sikorski et al. 1990).  Proteins containing several TPR- 
like domains seem to be especially involved in mitosis (Goebl and Yanagida, 1991; 
Oishi et al., 2007). 
An important mechanism to regulate protein action in cells is phosphorylation and 
dephosphorylation. As PTPIP51 seems to be involved in a multitude of signal 
pathways, its activity needs to be controlled tightly. Therefore, several serine and 
tyrosine phosphorylation sites can be found in the protein. Tyrosines are at positions 
53, 158, 176 und 300, whereas serines are at positions 44, 46, 50, 212, 225 (Brobeil 
et al., 2011a). 
 
 
 
 
3.  Interaction partners  of PTPIP51 
 
 
PTPIP51 is a multifunctional protein which can accomplish different functions by 
participating in several signalling cascades. Up to now, several interaction partners of 
PTPIP51 have been identified, either hypothetically or practically (Fig. 3). 
 
 
Fig. 3: Interaction partners  of 
PTPIP51, as determined by string 
software: 
FAM82A2: PTPIP51; C14orf166: 
UPF0568 protein C14orf166; DGKA: 
Diacylglycerolkinase α; NIN: 
Ninein; NUF: Nuf2; PTPN1-3: Protein 
Tyrosine Phosphatase non-receptor 
type 1-3; RAF1: v-raf-1 murine 
leukemia viral oncogene homolog 1; 
YWHAB: tyrosine 3- 
monooxygenase/tryptophan  5- 
monooxygenase activation protein, β 
polypeptide; YWHAG:   tyrosine 3- 
monooxygenase/tryptophan 5-mono- 
oxygenase       activation       protein, 
gamma   polypeptide;.  Many   these 
predicted interaction partners have 
already been proofed to interact with 
PTPIP51  in  vivo.Calculated  with 
string software, version 9.0 
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3.1 Interaction with phosphatases 
 
TcPTP was the first interaction partner of PTPIP51 to be identified (Stenzinger et al., 
 
2009). TcPTP is involved in apoptotic signal pathways, especially by increasing the 
expression of p53, a strong pro-apoptotic factor (Gupta et al., 2002; Radha et al., 
1999). The  interaction  between  TcPTP and  PTPIP51  has  not  been  investigated 
further yet. 
PTP1B is a protein tyrosine phosphatase that dephosphorylates several important 
proteins,  thus  influencing  intracellular  signalling  pathways.  It  is  upregulated  in 
different tumours, so it seems to be involved in tumourigenic processes (Wang et al., 
2011; Lessard et al., 2012). Overexpression of PTP1B leads to hypophosphorylation 
of several receptor tyrosine kinases, thus decreasing the activity of the associated 
signal pathways (Stenzinger et al., 2009). 
We could also find an association between PTPIP51 and PTP1B in adipose tissue 
which could be related to the insulin sensitivity of the investigated animals. PTP1B is 
already known to interact with the insulin receptor. Knockout of PTP1B in mice 
prevented them from adiposity, even after high fat diet (Klamann et al., 2000). This 
effect seems to take place mainly due to knockout of PTP1B in liver and skeletal 
muscle. PTP1B in adipose tissue seems to play a minor role in this action. Recent 
research in this area revealed that PTP1B has an influence on lipogenesis in adipose 
tissue (Owen et al., 2012). 
Our experiments concerning the role of PTP1B interaction with PTPIP51 revealed 
that it is an essential factor in the interaction of PTPIP51 with 14-3-3β. Those 
experiments showed that PTP1B mediated dephosphorylation on tyrosine 53 or 
tyrosine 158 lead to an interaction of PTPIP51 with 14-3-3β and raf-1, whereas 
phosphorylation of these two sites resulted in dissociation of the complex (Brobeil et 
al., 2012). 
Therefore, PTP1B seems to be one of the most important regulators of PTPIP51 
function. Its impact on the action of PTPIP51 in adipose tissue has been investigated 
recently  (Bobrich  et  al.,  2011).  The  interaction  of  both  proteins  seems  to  be 
correlated to the status of insulin sensitivity, but the exact impact of this interaction is 
still not well known. 
INTRODUCTION 
10 
 
 
 
 
3.2 Interaction with 14-3-3β 
 
14-3-3β is a crucial protein for MAPK pathway activation. Activation of this pathway 
leads to several changes in the cells, for example an increase in proliferation and 
differentiation (Yu et al., 2008). Thus, an increase in 14-3-3β can be found in different 
tumours, for example hepatocellular carcinoma or glioblastoma multiforme (Liu et al., 
2012; Petri et al., 2011). In glioblastoma multiforme, 14-3-3β expression correlates to 
the grade of malignancy (Petri et al., 2011). Recent investigation concerning the 
relation between PTPIP51 and 14-3-3β in glioblastoma multiforme revealed an 
association of both, hence PTPIP51 expression seems also to correlate with the 
grade of malignancy. Controversially, the MAPK pathway seems to be involved in 
both lipogenesis and lipolysis in adipocytes (Gehart et al., 2010). An association 
between PTPIP51 and 14-3-3β was found in several tissues and cell culture systems. 
In adipose tissue, the interaction between both depends on the grade of insulin 
sensitivity. Several studies revealed that the interaction of PTPIP51 and 14-3-3β 
influences the MAPK pathway (Yu et al., 2008; Stenzinger et al., 2009; Bobrich et al., 
2009; Brobeil et al., 2012). Interaction leads to an activation of raf-1. This activation 
stimulates the MAPK pathway, which is an important regulator of proliferation and 
differentiation (Brobeil et al., 2012). 
 
 
3.3 Interaction with kinases 
 
C-src is a kinase that plays an important role in mitosis (Brobeil et al., 2012). It is 
overexpressed in several tumours and in healthy tissue. Recently, c-src was found to 
influence the MAPK pathway through phosphorylation of tyrosine residue 176 in 
PTPIP51. Thus raf-1 is activated to stimulate the MAPK pathway (Brobeil et al., 
2012) 
 
Protein kinase A (PKA) fulfils a multitude of functions. It regulates calcium signalling 
(Vang et al., 2001) as well as the MAPK pathway (Wu et al., 1993). It also plays a 
role  in  apoptosis  (Lizcano  et  al.,  2000).  In  adipocytes,  PKA  mediates  the  β- 
adrenergic signal of catecholamines which leads to lipolysis (Collins et al., 2004). Its 
interaction with PTPIP51 seems to downregulate the inhibitory action of the IR on 
adenylylcyclase and to increase the lipolytic activity of the MAPK pathway (Bobrich et 
al., 2012). 
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Several receptor tyrosine kinases have been found to interact with PTPIP51. The 
epithelial growth factor receptor (EGFR) promotes proliferation. It is important in 
malignant transformation of glioblastoma multiforme and HNSCC (head and neck 
squamous  cell  carcinoma)  of  the  oropharynx.  In  glioblastoma  multiforme,  a 
correlation between PTPIP51 and EGFR could be found (Petri et al., 2011). In 
HNSCC, a colocalization between PTPIP51 and the membranous EGF receptor 
seems likely (Planz, personal communication). The Insulin receptor (IR) activates 
several pathways following activation by insulin. Its functions in different organs such 
as liver or skeletal muscle aim to decrease blood glucose levels. Thus, it induces the 
translocation of specific glucose transporters to the plasma membrane. In adipose 
tissue it also increases lipogenesis and suppresses lipolysis (Bobrich et al., 2012). 
These effects can, at least partially, be mediated through PTPIP51 by direct 
phosphorylation. The tyrosine 176 phosphorylation of PTPIP51 leads to decreased 
interaction  with  14-3-3β.  Without  being  bound  to  PTPIP51,  14-3-3β  does  not 
stimulate the MAPK signal pathway and is able to inhibit PKA through interaction with 
phosphodiesterase 3B (PDE-3B) (Onuma et al., 2002; Bobrich et al., 2012). 
 
 
The MAPK pathway is an important pathway in adipose tissue where it can either 
promote lipolysis or lipogenesis (Gehart et al., 2010). 14-3-3β is an interesting protein 
in adipocytes as it is able to interact with phosphodiesterase 3B (PDE-3B), thus 
decreasing the intracellular cAMP levels (Onuma et al., 2002). This leads to 
decreased lipolysis. As the interaction partners of PTPIP51 are important in 
adipocytes, we investigated the expression and interaction profile of PTPIP51 in 
adipose tissue in relation to the metabolism of the investigated individuals. The main 
focus of these investigations lies on the balance between lipolysis and lipogenesis, 
as imbalance between both can cause obesity. 
 
 
 
 
4.  Adipose  tissue 
 
 
 
4.1 Energy storage 
 
Excessive energy in the body is stored in the form of fat, consisting of esters of 
glycerin and fatty acids. Fatty acids are absorbed in the intestine and are further 
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processed in the liver. They are converted to triglycerides and transported through 
the hepatocyte cell membrane to the blood as very low density lipoproteins (VLDL). 
VLDLs are transported via the blood stream to the adipose tissue, especially to the 
visceral adipose tissue. Several enzymes convert triglycerides into free fatty acids 
which can get incorporated into fat molecules and stored as fat droplets (Dallinga- 
Thie et al., 2010). 
Adipocytes are highly specialized cells that represent the most important energy 
storage of the body. In case of energy demand fatty acids are transferred to the liver 
where they are converted into energy in form of ATP. To ensure a constant high 
energy level in the body, adipose tissue needs to be a dynamic storage which easily 
and  quickly  can  take  up  and  release  fatty  acids.  These  functions  need  to  be 
controlled tightly, e.g. by hormones. Several hormones, such as insulin, epinephrine 
or glucagon influence adipocytes by binding to specialized receptors on the cellular 
surface. 
Insulin, a multifunctional hormone, especially influences muscle, liver and adipose 
tissue  where  it  induces  several  intracellular  changes.  One  important  function  of 
insulin is its ability to increase glucose uptake by the translocation of the glucose 
transporter 4 (GLUT-4) to the cell membrane (Choi et al., 2010). In adipocytes, 
insulin  acts  lipogenic  by  tyrosine  phosphorylation  of  several  proteins,  especially 
insulin receptor substrate 1 (IRS-1) and antilipolytic by the inhibition of the lipolytic 
cAMP-activated  kinase  A  (PKA)  (Gual  et  al.,  2005;  Choi  et  al.,  2010).  PKA 
inactivation is mainly conducted by phosphodiesterase 3B (PDE-3B), a protein that is 
activated via Akt signalling (Ahmad et al., 2007; Kitamura et al., 1999). PDE-3B is not 
only activated via Akt but also through 14-3-3β (Onuma et al., 2007). The 14-3-3β 
protein (Onuma et al., 2002) interacts with the MAPK pathway not only in adipose 
tissue but also in several other tissues. As PTPIP51 interacts with 14-3-3β in adipose 
tissue, we assume that it might play a role in the metabolism of adipocytes. 
The opponents of insulin, epinephrine and glucagon, bind to different receptors, 
namely β-adrenergic receptors resp. glucagon receptors. Both act lipolytic through 
the activation of adenylylcyclase, thus increasing intracellular cAMP levels and PKA 
activity (Duncan et al., 2007). 
Lipolysis and lipogenesis can only be regulated by interplay of both regulation 
mechanisms. Thus, the lipolytic and lipogenic pathways are connected via several 
proteins  which  can  act  as  switchers  between  both  pathways.  Protein  Tyrosine 
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Phosphatase  Interacting  Protein  51  (PTPIP51)  is  involved  in  a  broad  panel  of 
 
regulations. It could possibly play a role in the modulation of both pathways. 
 
 
 
4.2 Obesity 
 
The number of obese people in developed countries steadily increases. Obesity is 
defined through a body-mass-index (BMI) of above 30 kg/m2. Metabolic changes in 
the obese individual abet several diseases such as diabetes type II, atherosclerosis 
or impaired wound healing (Sibal et al., 2011; Tirosh et al., 2011; Xing et al., 2011). 
Recent findings point out that adipocytes play an important role in energy balance, 
although adipocyte differentiation does not seem to cause obesity itself (Rosen et al. 
2006). However, adipocytes seem to play an important role in the development of the 
metabolic syndrome (Barth, 2011). Adipose tissue does not only possess the ability 
to store fatty acids, it is also an important regulatory and hormone producing organ 
(Wozniak et al., 2008). Adipose tissue produces several cytokines like adiponectin 
and leptin. Both are mediators that influence the energy state of individuals (Li, 2011; 
Ahima and Osei 2008; Hotta et al., 2008; Rosen and Spiegelman 2006). 
Adipokines, produced by adipocytes, are suspected to play an outstanding role in the 
development of the metabolic syndrome, especially when the balance of adipokines 
is disturbed (Tersigni et al., 2011). The adipokine production is influenced by the 
metabolism of the adipocyte and by the activation levels of several signalling 
pathways, such as the PKA signalling pathway (Than et al., 2011). Insulin and leptin 
seem to exhibit overlapping actions through activation of different pathways in the 
body (Scherer et al., 2011). 
 
 
4.3 Adipocyte metabolism 
 
Fatty acids are stored as triacylglycerids (TAG). There are two ways to produce TAG 
in adipocytes. One way is de novo lipogenesis. In human adipocytes, de novo 
lipogenesis seems to play a minor role in TAG genesis, as it has been found in 
several investigations (Sjostrom 1973; Lafontan, 2008; Roberts et al., 2009). Recent 
findings by Collins et al. (2009) revealed that de novo lipogenesis might play a more 
important role in the membrane lipid generation. 
The more frequented way in the generation of TAGs is its formation from fatty acids 
that  accumulate  within  the  bloodstream  as  chylomicrons  or  very  low  density 
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lipoproteins (VLDLs). The lipolysis of these particles takes place in the lumen of the 
blood  vessels  (Goldberg,  1996).  The  lipoprotein  lipase  (LPL)  is  secreted  by 
adipocytes and released into the luminal space where it is bound to 
glycosaminoglycans on endothelial cells. The hydrolysis of both lipoproteins results in 
non-esterified fatty acids (NEFA) which can be absorbed by adipocytes. 
FATP1 is one of the membrane-bound transporters for fatty acids. It does not play an 
important  role  in  the  basal  fatty  acid  uptake,  but  it  is  important  in  the  insulin 
stimulated fatty acid uptake (Lobo et al., 2006). Its translocation is stimulated by 
insulin, whereas its expression is increased by PPARγ and decreased by insulin 
(Lobo et al., 2006). These in vivo findings have recently been corroborated by in vitro 
experiments (Lenz et al., 2011). 
Besides FATP1, another fatty acid transporter protein namely FATP4 has been 
detected in adipocytes. The role of FATP4 has not been fully determined yet. Its 
knockout does not influence the fatty acid mobilization in adipocytes, but lipolysis 
seems to be downregulated (Lenz et al., 2011). 
 
 
 
4.4 Two important pathways in adipocytes 
 
Important regulatory hormones in adipose tissue metabolism are on the one hand 
insulin and on the other hand epinephrine and glucagon. They fulfil opposing 
functions. Insulin increases glucose uptake and promotes lipogenesis, whereas 
epinephrine and glucagon induce lipolysis. 
Insulin acts by activation of the insulin receptor. Extracellular binding of insulin leads 
to autophosphorylation of the two intracellular β-subunits, thus activating these 
subunits. The insulin receptor itself activates several molecules by tyrosine 
phosphorylation in favour of the following signalling cascades. One of them is the 
insulin receptor substrate 1 (IRS-1), a protein which induces most of the insulin 
actions in adipocytes. For example, IRS-1 is able to induce trafficking of intracellular 
glucose transporters to the plasma membrane (Peres et al., 2009). These GLUT-4 
transporters increase glucose uptake into the cell. The insulin receptor also plays a 
role in the MAP kinase pathway, the Cbl-associated protein (CAP)/Cbl pathway, 
PI3K/Akt pathway or PTEN (Siddle, 2011). To sum up, the insulin receptor controls 
the metabolism in adipocytes in many different ways. 
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Adrenaline, as an antagonist of insulin, augments blood glucose levels and lipolysis. 
Its function in adipose tissue is mediated by two different receptors, α- and β- 
adrenergic receptors. 
Adrenaline is able to either provoke lipolysis, mediated by β2-adrenergic receptors 
or, to a minor percentage, to initiate antilipolytic pathways by the activation of α2- 
adrenergic receptors. Β2-adrenergic receptors induce lipolysis through activation of 
adenylyl-cyclase. Activated adenylyl-cyclase transforms ATP into cyclic AMP (cAMP) 
which in turn activates the cAMP dependent protein kinase A (PKA) (Mantovani et 
al., 2009; Lafontan, 2008). Protein kinase A thereupon initiates lipolysis (Mantovani 
et al., 2009). Α2-adrenergic activation leads to opposite effects by inhibition of 
adenylyl-cyclase and PKA. (Lafontan, 2008). 
PKA activity is the first step of the following downstream pathway. Thus, PKA is a 
constitutive kinase for the regulation of adipocyte energy status (Omar et al., 2009). 
PKA activity is inhibited by the activated insulin receptor (Aitken, 2006). Amongst 
other effects insulin signalling results in the activation of phosphodiesterase 3B, 
which in turn hydrolyses cAMP, thus reducing the lipolytic activity of cAMP activated 
PKA (Lafontan, 2008). 
PTPIP51 is involved in several signalling cascades. It interacts with 14-3-3β, 
influences the MAPK pathway and is controlled by receptor kinases such as the 
insulin receptor. All those reasons make PTPIP51 a possibly interesting target in 
diabetes and obesity, as the named proteins play important roles in the metabolism 
of adipocytes. Therefore, we investigated PTPIP51 in adipose tissue. 
 
 
 
 
5.  Experimental setup to determine  the role of PTPIP51 in adipose tissue 
 
 
 
To  enclose  the  role  of  PTPIP51  especially  in  the  metabolism  of  adipocytes  we 
created mouse models with different states of insulin sensitivity. To accomplish these 
models, several groups of 10 mice each were distributed to different types of feeding 
and physical activity. The control group was fed a standard diet. Another group was 
fed a standard diet and trained on a running wheel at 80% of individual oxygen 
consumption to obtain a significant endurance training effect (Fig. 4). The third group 
was fed a high fat diet, and the fourth group was fed a high fat diet and submitted to 
the same training protocol as the second group. 
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Fig.4: Experimental 
setup 
A: Running wheel 
B: Spirometry to 
determine the 
maximum oxygen 
consumption. 
After a defined time interval, a glucose 
tolerance test was performed. The test 
revealed  that  the  high  fat  diet  mice 
had high blood glucose levels, even 2 
hours after application of glucose. 
Training in these mice lowered the 
values. Normal fed mice displayed 
normal blood glucose levels, 
independent of the training state. After 
the glucose tolerance tests, the mice 
 
were killed and the visceral adipose tissue was investigated.  PTPIP51, PTP1B, 14- 
 
3-3β, PKA and the IR in adipocytes were identified by immunofluorescence. To 
confirm possible interactions, a Duolink proximity ligation assay was performed. To 
review the principle of the Duolink proximity ligation assay, please refer to figure 5. 
PCR experiments detected PTPIP51 mRNA in adipose tissue of all investigated 
groups and could link its expression to the expression of PTP1B and 14-3-3β. 
 
Fig. 5: Principle of the Duolink 
proximity ligation assay 
 
The hybridization of the detection 
probes leads to a point-shaped 
signal, which can be quantified in 
special computer programmes. 
The  amount  of  dots  per  cm³ 
tissue can be compared to other 
probes of the same tissue. 
 
 
 
 
Our experiments revealed that PTPIP51 interacts with PTP1B, 14-3-3β, PKA and the 
insulin receptor (IR), in correlation with the state of insulin sensitivity. 
A partial colocalization in the immunofluorescent labelled probes could be detected 
for PTPIP51 with all investigated proteins. Interaction profi les differed widely. Animals 
fed a high fat diet displayed reduced interaction of PTPIP51 with PTP1B and 14-3- 
3β, whereas interaction with the IR was significantly increased. Submitting high fat 
diet animals to endurance training led to a slight increase in the interaction with 
PTP1B and the IR, a strong increase in 14-3-3β interaction and no significant 
difference in PKA interaction. Endurance training in normal fed animals led to a 
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further  decrease  of  interaction  with  the  IR  compared  to  all  other  groups.  PKA 
 
interaction showed a very strong decrease. 
 
 
 
 
 
6.  Role of PTPIP51 in adipose tissue 
 
 
 
Basing on our results, we assume that PTPIP51 acts as a switcher between lipolytic 
and antilipolytic pathways in adipocytes. 
The insulin receptor interacts with PTPIP51, probably phosphorylating PTPIP51 at 
Tyrosine 176. This phosphorylation site is known to influence the interaction profile of 
PTPIP51, especially with 14-3-3β. Phosphorylation at Tyrosine 176 decreased the 
interaction of PTPIP51 with 14-3-3β in HaCaT cells (Brobeil et al., 2012). In 
consequence the activation of the MAPK pathway was reduced in those cells. This 
mechanism is probably transferable to the regulation of the MAPK pathway in 
adipocytes. Phosphorylation of PTPIP51 at Tyrosine 176 could lead to a decrease in 
the  interaction  between  PTPIP51,  14-3-3β  and  raf-1  thus  reducing  the  MAPK 
pathway activity. Instead, 14-3-3β could interact with other proteins, most likely 
phosphodiesterase 3B (PDE-3B). Stimulated PDE-3B is able to influence PKA. The 
interaction of 14-3-3β with PDE-3B is known to decrease the activity of PKA, thus 
inhibiting lipolysis. 
As has been known for long, PTP1B plays a crucial role in the development of 
diabetes and obesity. PTP1B knockout mice are unable to develop adiposity, not 
even when submitted to high fat diet (Ali et al., 2009). So far, PTP1B in adipocytes 
seems to play a minor role in the development of adiposity. Previous knockout 
experiments identified especially liver PTP1B and muscle PTP1B to be important. 
Although the definite role of adipocyte PTP1B still remains unclear, it seems to 
dephosphorylate proteins in the insulin signalling pathway (Venable et al., 2000). 
Recent investigations concerning the role of PTP1B in adipocytes state that adipose 
tissue specific deletion of PTP1B increases lipogenesis (Owen et al., 2012). 
PKA interacts with PTPIP51 by phosphorylating it at Ser46. This phosphorylation site 
is crucial for binding of PTPIP51 to 14-3-3β and its interaction with raf-1. These 
interactions result in activation of the MAPK pathway (Bobrich et al., 2012). The 
interaction pattern of PKA and PTPIP51 leads to the assumption that it increases the 
lipolytic action of the MAPK pathway in adipocytes by phosphorylation of PTPIP51. 
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Our experiments showed that, in states of physical training, interaction between PKA 
and PTPIP51 is reduced. This seems controversial, especially if PTPIP51 is a 
mediator of the lipolytic action of PKA. But there is another, very potent interaction 
partner of PKA. The hormone sensitive lipase (HSL) is a strong activator of lipolysis 
(Campbell et al., 2009; Collins et al., 2004). A switch of PKA from PTPIP51 to HSL to 
force lipolysis seems most likely. We hypothesize that PTPIP51 acts as a switcher 
between the lipolytic action of PKA and the antilipolytic action of the IR (Fig. 6). 
 
 
 
Fig. 6: Possible  function of 
PTPIP51 in adipose t issue 
The insulin receptor 
phosphorylates  PTPIP51  at 
tyrosine 176.  This  leads to 
interaction of  the PTPIP51- 
14-3-3β-complex with 
PDE3B, thus leading to a 
decrease in the PKA- 
activating cAMP-levels. 
β-adrenergic receptor 
activation  in  contrast  leads 
to an increase in cAMP- 
levels and PKA activation. 
PKA phosphorylates 
PTPIP51 at serine 46, thus 
activating the lipolytic MAPK 
pathway  through  activation 
of  raf-1.  The  impact  of 
PTP1B dephosphorylation of 
PTPIP51 in adipose tissue is 
not yet clear. 
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7.  Prospect 
 
 
 
The impact of PTPIP51 on adipose tissue metabolism is still not fully understood. Our 
investigations linked PTPIP51 to insulin and PKA signalling in adipocytes. Yet, there 
are numerous other pathways, so the definite role and importance of PTPIP51 in 
adipocytes is not completely understood. Functional assays in PTPIP51 knockout 
models could enclose the role of the protein in adipocyte metabolism. Furthermore, 
PTPIP51 expression in other insulin dependent organs like liver, pancreas or skeletal 
muscle will enrol more details of PTPIP51 effects on fatty acid metabolism. Thus, 
further investigations are needed to identi fy the role of PTPIP51 in the development 
of metabolic syndrome and diabetes. 
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III. Summary 
 
 
 
The thesis aimed to investigate the expression and interaction profile of Protein 
tyrosine phosphatase interacting protein 51 (PTPIP51) in adipose tissue. Several 
groups of mice were trained and fed different diets to obtain different levels of insulin 
resistance. The training was held at 80% of maximum oxygen consumption, as an 
indicator for aerobe endurance training. The glucose tolerance of each mice was 
determined at the end of the test period. The expression profile of PTPIP51 in 
adipose tissue was investigated by immunofluorescence, PCR and Duolink proximity 
ligation assay. 
PTPIP51 was detected in all investigated samples. Its interaction partners PTP1B, 
 
14-3-3β, Insulin receptor (IR) and PKA also were expressed throughout all 
investigated groups. 
The  interaction  profi le  of  PTPIP51  with  its  interaction  partners  differed  widely 
between the groups. PTPIP51 interacts with PTP1B in trained high fat diet animals, 
normal diet animals and, to a lower extent, high fat diet animals. Interactions between 
PTPIP51 and 14-3-3β was highest in trained high fat diet animals, whereas it was 
lowest in high fat diet animals. IR-PTPIP51 interaction was highest in high fat diet 
animals and lowest in trained standard diet animals. Normal diet and trained high fat 
diet animals did not show significant differences. The interaction between PTPIP51 
and PKA was low in trained standard diet animals, all other groups did not differ 
significantly in their interaction profile. 
In conclusion, this thesis demonstrates the involvement of PTPIP51 in metabolic 
pathways. The protein seems to act as a switcher between the essential regulatory 
pathways for lipogenesis and lipolysis in adipocytes. 
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IV. Zusammenfassung 
 
 
 
Die  vorliegende  Arbeit  untersucht  die  Expression  und  das  Interaktionsprofil  des 
Protein  tyrosine  phosphatase  interacting  Proteins  51  (PTPIP51)  im  Fettgewebe. 
Hierzu wurden Mäuse in verschiedenen Gruppen trainiert und mit unterschiedlichen 
Futterzusammenstellungen  gefüttert  um  Unterschiede  in  der  Insulinresistenz  zu 
provozieren. Das Training wurde bei 80% der maximalen Sauerstoffausschöpfung 
abgehalten, um ein aerobes Ausdauertraining durchzuführen. Am Ende des Tests 
wurde die Glukosetoleranz der Mäuse bestimmt. Das Fettgewebe wurde mit Hilfe 
von Immunfluoreszenz, PCR und Duolink proximity ligation assay  untersucht. 
PTPIP51 wurde in allen untersuchten Tieren nachgewiesen. Auch die 
Interaktionspartner PTP1B, 14-3-3β, der Insulin Rezeptor (IR) und PKA wurden in 
allen untersuchten Gruppen exprimiert. 
Das Interaktionsprofil zwischen den Gruppen zeigte ausgeprägte Unterschiede. 
PTPIP51 interagiert mit PTP1B in trainierten fettgefütterten Tieren, in normal 
gefütterten und, in geringerer Ausprägung, in fettgefütterten Tieren. Die Interaktion 
zwischen PTPIP51 und 14-3-3β war am stärksten in trainierten fettgefütterten Tieren 
zu sehen, fettgefütterte Tiere zeigten die wenigsten Interaktionen. IR-PTPIP51- 
Interaktion war am höchsten in fettgefütterten Tieren und am niedrigsten in trainierten 
normal gefütterten Tieren. Normal gefütterte und trainierte fettgefütterte Mäuse 
zeigten keine signifikanten Unterschiede im Interaktionsprofil. Die Interaktion 
zwischen PTPIP51 und PKA war niedrig in trainierten normal gefütterten Tieren, die 
anderen Gruppen zeigten keine signifikanten Unterschiede. 
Diese Arbeit zeigt die Beteiligung von PTPIP51 in metabolischen Signalwegen. Das 
Protein  scheint  in  Adipozyten  als  Vermittler  zwischen  den  essentiellen 
regulatorischen Signalwegen der Lipogenese und Lipolyse zu agieren. 
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Objective: We investigated the express ion of protein tyrosine phosphatase-interacting protein 51 (PTPI P51) and its interaction 
with protein tyrosine phosp hat ase 1B (PTP1B) and 14-3-3b in mice exhibiting insulin resistance and obesity. 
Design: A total of 20 mice were included in the study. Eight control animals  were fed a normal standard diet, six animals  were 
fed a high-fat diet and six animals were submitted to a treadmill training paral lel to the feeding of a high-fat diet. After 10 weeks, 
a glucose tolerance test was performed and abdominal adipose tissue samples of the animals were collected. 
Results: PTPIP51 protein was identified in the adipocytes of all samples. PTPIP51 interacted with  PTP1B and with  14-3-3b 
protein. Compared with untrained mice fed a standard diet, the interaction of PTPIP51 with PTP1B was reduced in high-fat diet- 
fed animals. The highest interaction of PTPIP51 with 14-3-3b was seen in trained animals on high-fat diet, wherea s untrained 
animals on high-fat diet displayed lowest values. 
Conclusion: PTPIP51 is expressed in  adipose tissue of humans, rats  and mice. Obesity with enhanced insulin resist ance resulted 
in a reduction  of PTPIP51  levels in adipocytes and influenced the interactions with  PTP1B  and 14-3-3b.  The interaction 
of PTPIP51 with  PTP1B suggests  a regulatory function  of PTPI P51 in insulin receptor signal transduction. The interaction of 
PTPI P51 with 14-3-3b, espec ial ly in trained individuals, hints to an involvement of PTPI P51 in the downstream regulation of 
insulin action. 
International Journal of Obesity advance online publication, 25 January 2011; doi:10.1038/ijo.2010.283 
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Introduct ion 
 
Adipose tissue is  multifu n ctio n al. Its  main function is  its 
ability to  store  energy in  the  form of fatty acids. 
The storage of fat is t ightly r egulat ed by diff erent signalin g 
pat h way s. Two  of  the   mo st  im p o rt ant sign al t r an sd uct io n 
ways are the  in sulin  an d the  prot ein kin ase A (PKA) signalin g 
p ath way s, wh ich  o p po se each oth er ’s fun ctio n. In sulin  
inhibits lipolysis, whereas PKA activates it .1 
The   role   of   prot ein  tyro sin e  ph o sph at ases  (PTPs)  has 
been  descr ibed as crucial in in sulin  signal tran sduct ion. PTP s 
gain  im po rt an ce in in sulin- resist ant  stat es, as th ey act  as 
regulat or s of in sulin r ecepto r (IR) sign alin g. 2–4 In p articular , 
protein t yro sine  p ho sp h atase  1B (PTP1B) was  fo un d to  
depho sp ho rylat e the   IR and the   IR substr ate-1. 5,6  It   has  a 
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m ajor role   in  in sulin   r esist an ce an d  o besit y in  wh ich  its 
ex pression is up regulat ed.7 ,8 Mice lackin g a fun ct ion al PTP1B 
gene  are resist ant to weight gain  on a high- f at diet , an d sh o w 
in creased in sulin sen sitiv ity in  liver  an d sk eleta l m uscle.  
PTP1B-null mice  do  not exh ibit  in creased in sulin sen sit ivit y 
in  adipose tissue. 9 
Accordin g to  Asante-Ap piah and Kennedy,10  PTP1B regu- 
lates   the   resp on se to  IR  activ ation  by  dep ho sp h ory latio n 
of  IR  sub st rat e-1  an d  oth er  m olecules ph o sph o ry lated  o n  
tyro sine in r esp on se  to in sulin-m ediat ed sign alin g. Yet, up to  
no w,  the  ex act m ech an ism of PTP1B in the  regulat ion  of th e  
in sulin  sign alin g p ath way has   n ot be en  fully   establish ed, 
p art icular ly n ot in  adipo se  tissue. Nev erth eless, PTP1B an d  
its inter actio n p art n er s m ight beco m e im p o rtant new  target s 
for ph arm aceut ical  int erv entio n in in sulin -r esist ant  states of  
diabet es. 
Prot ein  tyro sin e p h o sp h atase- interact in g protein 5 1  
(PTPIP51),   a  protein  with   t issue- specif ic ex pressio n, tak es 
p art  in the  regulatio n  of pro lif er atio n, diff er entiation,  ap op - 
tosis  an d cell  m ot ility.1 1  PTPIP51  int er act s wit h PTP1B11 , 12  
and with several molecules that are located upstream  of the 
  
Values in kcal per 100 g Standa rd diet High-f at diet 
Protein 24 20 
Carbohy drates 65 35 
Fat 11 45 
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mitogen -activ ated  protein  kinase  pathway,  for   example, 
14-3-3 b,  a  prot ein t h at  is  able   to   act iv at e  the   m ito gen- 
activ ated  p rotein  k in ase  p ath way  thro ugh    dir ect  int er - 
action wit h raf-1. 13  The mit o gen-activ ated prot ein k in ase 
p ath way  is crucial for gro wt h an d dif f er ent iatio n o f 
adipocyt es. 1 4, 1 5 
We  an aly zed the   expressio n pro file of  PTPIP51  in  mice 
fed  a  st an dard diet   an d in  mice   fed  a  high -fat diet   that 
in d uces in sulin  resist an ce .16   As  in sulin  r esistance  is 
in fluen ced by  ph y sical activ ity,17   a  third gro up of  anim als 
fed  a high -f at  diet  was  sub m itt ed to  an  en duran ce t r ain in g 
proto co l. The  ex p ressio n  p att ern of PTP1B an d 1 4-3-3 b, an d 
the  analy sis of th eir int er actio n with  PTPIP51,  were in clu ded 
in  the  study. 
Our  exp erim ents r ev ealed a p art ia l association  of PTPIP51 
wit h  prot ein s  in vo lv ed  in   sign alin g  processes  in   adip o- 
cytes   fro m an im als un der  ph y sio lo gical an d  p ath o lo gical 
conditio n s. 
 
 
Materials  and methods 
 
Study design 
The   ex p er im ent s were   p erform ed with  Bl6  mice   (n ¼ 20). 
The  exp er im ent s were  ap prov ed by  the   local  Animal Care 
and Use Comm ittee (Gi 20/24 Nr 94 2010). 
The anim als were kept  un der st an dard con dit ion s (1 2-h  
ligh t/dark cycle)  an d fed ad libitum  wit h  free access  to water. 
The  experim ents were  run for 10 weeks. 
 
Control   group  (n ¼ 8).    The   an im als  were   fed   a  st an dard 
diet  (Altro m in stan dard-diet no.  1324 , Altrom in,  Lage, 
German y). For nutrient compo s itio n, see Table  1. 
 
High-fat  diet group (n ¼ 6).    The  anim als were  fed a specially 
assem bled high -f at diet  co nt ain in g 45%  fat.  For n utr ien t 
compo sit io n of the  high-fat diet, see Table  1. 
 
High-fat diet and training  group (n ¼ 6).    The anim als were fed 
a  high -fat diet  an d su b m itt ed to  en d uran ce tr a in in g on  a 
treadm ill for  35 min  five  t im es a  week.  The  animals  were 
accusto m ed to the  treadm ill 1 week  befo re  the  begin nin g of 
the  tra in in g.  The perfo rm an ce of the  anim als was contro lled 
by m easur in g VO2 max  usin g a sp iro m eter  (Arnfinn  Sira , 
Trondheim,   Norway).  Runnin g  velocity  was   adapt ed to 
80%  of VO2 max. 
The insulin r esist an ce was est im at ed by a gluco se to leran ce 
test   at   the   en d of  the   ex p er im ent al  p er io d. The  test   was 
performed by  an  intraper ito n eal injection of  2g kg-1   body 
 
Table 1   Energy  content of  the standard diet and the high-f at diet 
 
 
 
 
wei ght of  20%  D-Gluco se gluco se  disso lv ed in  ster ile 0 .9 % 
NaCl  so lut io n. Fastin g bloo d gluco se  levels  were  det erm in ed 
after  15,  45 and 90 min follo win g applicat ion . 18 
After 10 weeks,  the  anim als were killed  an d the  abdo m in al 
adip o se t issue was fro zen  in liq uid nitro gen p re-co o led 
isopent an and transfer r ed to  -80 1C till  further analysis. 
 
Quantitative  real-time PCR 
The  am p lif icat io n of cDNA was car ried out  in  25 ml react io n 
vo lum e on  the  iCycler  iQ Real-T im e PCR Detectio n Sy st em 
(Bio-Rad,  Mun ich, Germ any) . The  final  react io n t ubes  
co ntain ed 100 n M of PTPIP51,  PTP1B, 14-3-3 b an d r eferen ce 
gene    b- actin  p rim er,   12.5 ml   iQ   SYBR  Green  Sup ermix 
(Bio-Rad)  an d 2 ml  of  DNA  tem p late . The  PCR  co n dit io n s 
were  94 1C for 3 min followed by 40 cycles  for 30 s, 60 1C for 
30 s an d 72 1C for  1 min. Melt in g curv es were  generat ed fo r 
all genes  after amp lification.  Negativ e co ntro ls were in clude d 
in each  run . Pairs of ch em ically synt h esized o ligon ucleotides 
were  design ed usin g freely  av ailable pr im er design so ft ware 
(Pr im er3, http ://fro do. wi.m it. edu/p rim er3/).   Mo use-specif ic  
mRNA  tem p lates were  used  as  in p ut  seq uen ce.  All pr im er s 
used  in  this   study  are  list ed in  Table  2.  mRNA  expressio n 
levels   of  target genes   were   norm alized to  the   expression 
of  the  ho usekeepin g gene  b-actin  an d q uan t if ied usin g  t h e 
comparat iv e CT metho d.1 9 
 
 
PTPIP51  antibody production 
The    cDNA    sequen ce   en co din g   am ino   acids    1 31– 470 
was   in sert ed  into  the    BamHI   an d  Hin dIII   sites   of   the 
plasm id  pQE30   an d  ex pressed as  His6 -t ag ge d p rot ein in 
the  protease-def icient E. coli exp ressio n stra in  AD202  
(araD139 DE(argF- lac)169  om pT1000: kan    flhD5301   fruA25 
relA1 rps150(strR) rbsR22  deoC1).  The  prot ein was  p ur ified 
to electrop ho retic ho m o gen eity by ch ro m at o graph y on  a  
nickel– agaro se colum n .   Im m un izatio n  of  r abbit s was  per- 
form ed wit h  0.5 mg  of  the   pur if ied p rot ein  in  0.5 ml  RIBI 
adjuv ant fo llo wed by bo o st er inject io n s with 0.5 an d 0.3 m g 
on  days 14 an d 21, r esp ectiv ely. The antiserum  was co llect ed 
on  day 28. Monospecif ic antibodies were  prepared followin g 
the  method descr ibed by Olmsted. 20 Briefly, 2 mg of purified 
antigen  were  blott ed on  nitro cellulo se after  SDS electro-  
ph oresis.  The   prot ein   ban d  was   m ark ed  usin g  Po n ceau 
so lut io n  an d h ad been  cut  o ut .  After  blo ck in g of th e  
m em bran e  strip   wit h  1%   lo w-fat  milk   po wder  in   ph o s- 
ph ate-buff er ed salin e, the   m em bran e was  in cubat ed wit h  
the   antiserum  for  1 h follo we d by  ext en siv e wash in g wit h 
Tris-EDTA-buffered saline.  The  antibo dies were  eluted with 
0.2 M   gly cine  (pH   2.0)   for  2 min  fo llo we d by  im m e diat e 
neutralizat io n with 1 M  triethan o lam in e. 
 
Immunohistoch emistr y 
The  primary polyclon al antibo dy  to  PTPIP51  was  used   in 
1:10 0 0 dilut ion s  for  im m un o cyto ch em ist ry  an d v isualized 
by   Alexa   555   (Mo lecular  P ro bes,  Darm stadt,   Germ an y, 
cat.   no.   A21428). Primary monoclo n al  mouse  and  goat 
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Table 2   List of  the primers used f or quantitativ e reverse transcrip ta se  PCR experiments 
 
Target Sequence (50 –30 ) Product length, bp Exon Template 
PTPIP51 Forward (25 bp), GGTCCGCTCTCATATAGAAGAGAAC 70 3–4 510–579 
 Reverse (22 bp), CCTCTCTCTGGCAAAAGGGAAC    
PTP1B Forward (26 bp), CATCAAGAAAGTACTGCTGGAGATGC 144 ND 902–1045 
 Reverse (24 bp), TCCTTCCACTGATCCTGCACTGAC    14-3-3b Forward (24 bp), TGACAATCTTGTTAGTGCCTGTCA 
Reverse (24 bp), AATGTCAAGGTAGAGGGGTGAGAC 
175 ND 2132–2306 
Abbrev iations: ND, not determined; PTP1B, protein ty rosine phosph a t a se 1B; PTPIP51, protein ty rosine phosphatase-interacting protein 51. 
 
 
antibo dies were  used  for  double stainin g experim ent s with 
14-3-3 b an d PTP1B. The reactio n of the  prim ary m on o clon al 
m o use ant ibo dy  was  visualized usin g f luo rescein  isoth io -  
cy an at e-do n k ey -anti-m o use-F(ab)2  seco n dary  antibo dy  
(Diano v a,   Ham burg,   Germ an y,   cat.    no.    715-09 6-15 0). 
The   prim ary  m o no clo n al   goat    ant ibo dy   was   visualized 
usin g f luorescein isot hiocyan ate-m o use-anti-go at-Ig G secon-  
dary   antibo dy  (Si gm a-Aldr ich  Ch em ie  Gm bH, St ein h eim ,  
Germ an y,  cat.  no.  G2 904 ). Nuclei were  disp lay ed by  DAPI 
(4 0 ,6-diamid in o-2-ph eny lin do le) stainin g. 
Prim ary m o no clo n al m o use antibo dies used  for  do uble  
st ain in g exp erim ent s were  again st PTP1B an d 14-3-3 b (Santa  
Cruz  Biotech no lo gy, Sant a Cruz,  CA, USA, cat.  nos.  sc-171 8  
an d  sc-25 2 76) . The   reactio n  of  the   prim ary  m o n o clo n al 
m o use antibo dy  was  visualized usin g Alexa  Fluor  48 8  
secon dary antibo dies (Molecular Pro bes, Darm st adt, Ger -  
m an y,  cat.   no.   A110 01).  Nuclei  were   disp lay ed  by  DAPI 
stainin g. 
Five  samp les  of  rat   adip o se  tissue an d  t wo   samp les  of 
h um an   v isceral adip o se tissue were  used  for  im m un o -  
cytochemist ry. 
All  sam ples  of  m o use,  h um an   an d  rat   were   an alyzed 
and representat iv e samples were  docum ent ed. 
 
 
Duolink  proximity  ligation  assay 
Int eract ion   of   PTPIP51    wit h  e ith er  PTP1B   or   14-3-3b 
was  det ect ed by  the   Duo Link prox im ity ligat ion assay  k it  
(DPLA; Olin k bio scien ces,  Up p sala, Swe den; PLA pro be ant i-  
rab bit  m in us  for   the    det ect io n  of   the    rabbit   PTPIP51 
antibo dy,  cat.   no.   90602 ; PLA pro be anti-m o use  plus   for 
the   det ectio n of  the   mo use ant i   PTP1B  or  14-3 -3 b ant i- 
bo dy, cat.   no.   90 70 1; Detection  Kit  563,   cat.   no.   901 34) . 
The  DPLA seco n dary  an tibo di es o n ly  h y br i dize  wh en  t h e 
two  diff er ent PLA pro bes (p ro be anti-r abbit m in us an d pro be  
anti-m o use plus)  h av e bo un d to  protein s in  such pro xim ity  
th at t h ey are  closer   than 40 n m .  After  ligation,  fo rm in g a  
c ir cular  tem p lat e,  an d am p lif icat ion  step,  the  fluorop ho re-  
co up led t est in g pro be bin ds the  am p lified o ligo n ucleotide  
str an ds. Ad dit io n of  the   fluo rescently  labeled o ligo n ucleo-  
tides    th at   h y br idize  to   the    rollin g  circle    am plif icatio n 
pro duct  leads  to  a point- sh ap ed sign al t h at is visible  in  
fluorescen ce microsco p y. 
Meth an ol-f ix ed air -dr ied samp les were  in cu bat ed wit h  
blockin g agent for 1 h. After  washin g in  phosphate-b uff ered 
saline  for   10 min,  pr im ary  antibo dies  for   PTPIP51   an d 
PTP1B,  resp ectiv ely  1 4-3-3 b were   ap plied to  the   samp les. 
The  antibo dies were  dilut ed in  the  blo ck in g agent in  a  
con centr at ion  of  1:500  an d 1 :10 0, r esp ectively.  In cubat ion  
was    car ried   out    o v ernight   in    a   p r e-h eat ed  h um i dity 
cham ber.  Slides   were   wash ed th ree  t im es  in   ph o sp h at e- 
buf fered salin e for  10 m in.  Duo lin k PLA p ro bes detect in g 
rab bit or  mo use antibo dies  were   dilut ed in  the   blocking 
agent  in  a  co n centr at io n  of  1:5  an d app lied to  the   slides 
fo llo win g  in cubat io n  for   2 h  in   a   pr e-h eat ed h u m idity 
cham ber   at    37 1C.   Wash in g  th ree  t im es  in   pho sp h ate- 
buf fered salin e for  10 min  r em o v ed un bo un d PLA pro bes.  
For  hy bridizat ion  of  the  two  Duolink PLA p ro bes, Duo lin k 
hy br idizat ion stock   was  dilut ed in  the   ratio 1:5  in  high - 
p ur ity  wat er  an d  slides   were   in cubat ed  in   a  pre-h eated 
h um idity  ch am ber  for   15 m in  at   37 1C.   The   slides   were 
wash ed  in   tris-buff er ed  salin e-T ween  20  for  1 min  un der 
gent le  agit ation . The  samp les were  in cu bat ed in the  ligat io n 
solutio n  co n sistin g  of   Duo link  L igation  stock   (1:5)   an d 
Duo link Ligase (1:40)  dilut ed in h igh-p urit y wat er for 90 m in 
at 37 1C. Detect io n of the  am plif ied pro be was do n e wit h t h e 
Duo link Det ectio n kit .  Duo lin k Detect io n stock  was dilut ed 
in  the  ratio 1:5  in  high-p urit y water and applied for  1 h at 
37 1C. Final  wash in g steps  were  carr ied o ut  by salin e- so dium  
citrate buffer  and 70%  ethano l. 2 1, 2 2 
 
 
Analysis  of DPLA results 
The  Blo bFin der  soft ware f ro m  the  Centr e  for Im age An aly sis 
Quan tif icat ion was used  for quant if icatio n of the  detect ed 
DPLA signals.2 3  Po sitiv e  r eaction  dots  of the  DPLA, in dicat - 
ing the  int er act io n of the  analy zed protein s (PTPIP51,  PTP1B 
an d 14-3-3 b) were  co unt ed.  Sen sit iv it y an d blob  thresh o ld 
were  set identically for all probes. 
 
 
Fluorescence  microscopy 
The   Axiop lan  2  fluo rescen ce  m icro sco p e eq uip p ed  wit h 
Plan-Apo ch ro m at  o bjectives  (Carl   Zeiss,   Jena,   Germ any) 
was   used   for   phot o  do c um en t at ion . For  visualization  of 
the   seco n dary  ant ibo dy,  Alexa   Fluor   555,   an   ex citat ion 
filter  with a sp ectrum  of 530– 560 n m an d an  emission f ilt er 
wit h  a sp ectrum 57 2–6 47 n m were used. Alexa Fluor  488 was 
visualized by  an  ex cit atio n  filter  in  a ran ge of 46 0–5 00 n m 
and an  emission filter  in  a range of 512–542 nm. 
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perinuclear region and was low in the  cytoplasm . In human s 
and   mice,  PTPIP51    was   distrib uted  within  the    whole 
In  prelim in ary exp er im ent s,  PTPIP51  was sho wn  to  be  
exp ressed  in   adipo se  t issue  of  diff er ent  sp ecies,  nam ely, 
m o use, rat  an d h um an s.  Yet, subcellular lo calization  of  
PTPIP51  diff er ed wit hin  the  inv estigat ed species  (Figure  1). 
In    rat    adipocytes,   PTPIP51    was    concentr at ed   in    the 
cytoplasm, with higher concentr atio n s in the  nuclear region. 
Owin g  to   the   fact   of  comparable  expression  values  of 
PTPIP51   in   human  and  mice   adipose  t issue,  mice   were 
used  in  this  study. 
 
 
 
Glucose tolerance  test and  weight  gain 
After  10 weeks  of bein g fed on  high -fat diet  or high- f at diet 
an d en d uran ce tr a in in g prot o co l,  the  gluco se to leran ce was 
det erm in ed.  As sh o wn  in Table  3, 15 m in after  gluco se load, 
bloo d  gluco se  con centrat io n s  in creased to  130%   of  basal 
values in  control  animals, which almost normalized after 
45 min and reached basal  values after  90 min. 
The    high- fat   diet-f ed  an im als   exh ibited   a   dif f er ent 
respo n se to gluco se. Mean gluco se con centr atio n s were m o re 
th an  do u bled at  15 m in after   gluco se  load   an d st ay ed at 
higher levels  even at 90 min post  injection . 
High -f at diet- fed an d tr a in ed anim als su bjected to  the  
gluco se tolerance test  displayed glucose values of  180%  at 
15 min, 158%  at 45 min and 132%  at 90 min. 
Over   the   exp er im ent al  p erio d,  the   weight  gain   of  th e 
an im als  diff ered  wit hin   the    thr ee   gro up s.  No rm al-f ed 
anim als h ad a m ean  weigh t gain  of  46%,  high-f at diet- fed 
an im als gained 132%  an d the  high- f at die t- f ed an d tr a in ed 
mice  gain ed 128%  (Table 4). The weight gain  was r ef lected by 
in creased size of adipo cyt es basin g on  the  elev ated calor ic  
int ak e.  Adip ocytes f ro m mice  on  high- f at diet  displayed t h e 
high est vo lum es,  wh ereas adip o cyt es fro m co ntro l anim als 
were  smallest (Figure  2). 
 
 
 
PTPIP51  protein  and  mRNA expression 
PTPIP51  protein in adipose tissue sections from mice  fed on 
a control diet, a high-fat diet  or a high-fat diet  accomp an ied 
 
 
 
Table 3   Av erage blood glucose concentration af ter intraperitoneal applica- 
tion of  glucose solution 
 
Bef ore 
application 
 
At 15 min af ter 
application 
 
At 45 min af ter 
application 
 
At 90 min af ter 
application 
 
Standard diet fed   148.0±21.4    205.25±47.8 163.6±42.5 138.6±24.4 
High-f at diet fed     170.2±25.2 403.2±98.0 415.3±70.8 353.3±65.5 
High-f at diet fed 
and trained 
153.6±26.6 277.2±64.6 243.2±50.4 202.0±35.2 
 
 
 
Table 4   Mean weight of  the animals of  all three inv estigated groups at the 
beginning (week 0) and the ending (week 10) of  the test period 
 
 
Figure 1   Immunostaining of  PTPIP 5 1 in adipose tissue of  mouse, rat and 
human. (a) Mouse adipose tissue; (b) rat adipose tissue; (c) human adipose 
ti ssu e. Nuclei are stained using D AP I.  Arrows, high PTPI P 51 concentrations in  
the perinuclear area. Bar, 10 mm. 
 
Week 0  Week 10 
 
Standard diet f ed 20.1±1.1 29.4±1.7 
High-f at diet f ed 19.5±1.3 45.3±2.3 
High-f at diet f ed and trained  18.8±1.3 42.9±4.2 
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Figure 2   Immunostaining  of PTPI P5 1 in mouse adipose tissue. (a) Adipose tissue of standard-diet-f ed animal; (b) adipose tissue of high-f at diet-f ed animal; 
(c) adipose tissu e of  animal f ed on high-f at diet and subjected to training. Nuclei are stained using D A PI . Ar rows, high P TPIP 5 1 concentrations in the perinuclear 
area. Bar, 20 mm. 
 
 
 
 
 
Figure 3   Immunostaining of  PTP1B  protein (a–c) and PTPI P5 1 (d–f ). (a) PTP 1B in a di p o se  ti ssu e  of  standard-diet-f ed animal; (b) PTP1 B in a di p o se  ti ssu e  of  high-f at 
diet-f ed animal; (c) PTP 1B  in adipose tissue of  animal f ed on high-f at diet and subjected to training; (d) PTPI P5 1  in adipose tissue of  standard-diet-f ed animal; 
(e) P TPI P 51  in a di p o se ti ssu e of  high-f at diet-f ed animal; (f ) PTPI P5 1 in a di p o se  ti ssu e  of  animal f ed on high-f at diet and subjected to training. Nuclei are  stai n e d  using 
DAPI. Arrows, co-localization of  PTP1B and PTPIP51. Bar, 50 mm. 
 
 
 
by  an  en durance tr eadm ill  tr a in in g r egim en was  ident if ied 
by   a   specif ic po lyclon al  antibo dy.  In dep en dent   of   the 
pre-tr eat m ent of the  mice, PTPIP51  prot ein  was traceable in 
adip o se tissue of all mice  (Figure  2). Adip ocytes fro m  high -f at 
an im als disp lay ed a  m uch  weak er PTPIP51  react io n  wh en  
co m p ared with adip o cyt es fro m an im als fed a stan dard diet 
or  tho se fed  on  a h igh -f at diet  acco m p an ied by  a treadm ill 
tra inin g (Figure  2). In stan dard diet  an im als, PTPIP51 was 
con centr at ed aro un d  the  n ucleus. The  cyto p lasm  rem ain ed 
wi dely un st ain ed, except in  the  direct prox im ity of plasm a 
m em bran es.  In  adipo cytes f ro m  h igh- fat diet-f ed anim als,  
PTPIP51  was lo cat ed aro un d the  n ucle us an d the  cytop lasm 
rem ain ed un st ain ed. The  distr ibut ion  of PTPIP51 in anim als 
fed  on   high- f at diet   an d su bject ed to  en d uran ce tr a inin g 
co rr espo n ded to the  distr ib ut io n p att ern in  adipo cytes fro m 
standard diet  animals. 
Highest  v alues of PTPIP51 mRNA were observ ed in adipo se 
tissue of h igh-f at  diet-f ed an im als, wh ereas h igh-f at  diet-f ed 
an d tr ain ed anim als disp lay ed lo wer   am o un t s of  PTPIP51 
mRNA.   Norm al  diet    anim als   display ed   lo west   PTPIP 51 
mRNA levels  (Figure  4a). 
PTP1B protein  and  mRNA expression 
As  seen   by  im m un o st ainin g  ex p er im ent s,  PTP1B  prot ein 
was  exp ressed in  anim als of all  three gro up s (Figures  3a– c). 
The   prot ein  was   traceable  in   the   wh o le  cy to p las m  an d 
co -lo calized with  PTPIP51  mainly in  the  n uclear  r egion  
(Figures  3d–f).  No  diff er en ce in  the  PTP1B prot ein am o un t 
could be assessed. 
Highest v alues of PTP1B mRNA were seen  in adip o se tissue 
of  high -f at diet- f ed an im als, wh ereas st an dard-diet- f ed 
an im als disp lay ed lo wer  am o un t s of PTP1B mRNA.  High-f at 
diet-f ed an d tr ain ed an im als displayed lo west PTP1B mRNA 
levels  (Figure  4b). 
 
 
Interaction of PTPIP51  and  PTP1B 
To cor ro bo rate a  p o ssible interact io n of PTPIP51  and PTP1 B, 
a  DPLA was  app lied to  adipo se tissue sectio n s. The  int er-  
actio n  of  the   two  protein s was  eviden ced by  the   ligation 
of   the    PLA  min us   oligon ucleotide   identifyin g   PTPIP 51 
an d PLA plus  o ligo n ucleotide  ident ifyin g PTP1B. Ligated 
rolling circles  were  amplified by  polymerase activity, with 
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Figure 4   Quantitativ e real-time PCR  a nal ysi s of  PTPIP 5 1, P TP1 B and 14-3-3b  
in adipose ti ssu e  f rom mice fed a standard diet, high-f at diet or high-f at diet 
plus training. (a) Normalization a p p ro a ch e s  on the lev el of  PTP IP 51 gene; (b)  
normalization a p p ro a ch e s on the l e vel  of  PTP1 B; (c) normalization approaches  
on the lev el of  14-3-3b. Normalizations were made using b-actin as ref erence 
gene. 
 
 
su bseq uent   det ect ion   by   a   fluo rop h ore-co up led  test in g 
pro be. Each  amp lif icat io n co rr espo n ds to  a fluorescent dot.  
In adip o cyt es of all an im als, th ese hy br idized an d am p lif ied 
antibo dy -link ed  n ucleot ide  st r an ds  were   det ect ed,  with 
each dot  corr esp on din g to  an  inter act io n bet ween  PTPIP51 
an d PTP1B. As sho wn in  Figure  5, PTPIP51  an d PTP1B were 
dir ect ly  int er actin g  in  adip o cy t es in dep en den t f ro m  th eir 
pr e-tr eat m ent. Yet, the  inter actio n  was p art ia l an d the  ext ent 
dif f er ed stro n gly  bet ween  the   three  gro up s. The   high est 
grade  of inter act io n was o bserved in  the  adip o cytes deriv ed 
fro m  anim als on  st an dard diet,  with values bein g 1.7- fo ld 
higher  compared  with  the   interact io n  in   adipocytes  of 
 
 
 
 
an im als  fed   wit h  h igh - f at   die t.   An im als s u b m itt ed  to 
treadm ill  tr a in in g h ad an  int erm ediat e  int er actio n  grade 
(Figure  5). 
 
 
14-3-3b protein  and  mRNA expression,  and  interaction 
of 14-3-3b with  PTPIP51 
Im m un o st ain in g of 14-3-3 b protein in  adip o cytes disp lay ed 
its  expressio n in  animals of  all  three experiment al group s. 
14-3-3 b was  lo cated wit h in  the  cyto plasm  an d co- lo calized 
to  PTPIP51,  especially in  the  nuclear area  (Figure  6). 
Highest  values of  14-3-3 b  mRNA  were   seen   in  adipo se 
tissue of h igh- fat  diet-f ed an d tr a in ed an im als, wh ereas 
an im als fed  on  a stan dard diet  or  a high- fat  diet  disp lay ed 
low  amount s of 14-3-3b mRNA (Figure  4c). 
 
 
Interaction of PTPIP51  and  14-3-3b 
To pro be a po ssible  interact io n of PTPIP51  an d 14 -3-3 b,  t h e 
DPLA was  ap plied. PTPIP51  an d 1 4-3-3 b were  p art ia lly  
int er actin g in  all inv estigat ed sam p les, as ev idenced by a  
po sitiv e DPLA sign al (f luorescen ce dot s). The  extent of  
int er action diff er ed accordin g to  the  pre-t reat m ent. High est  
inter act io n  grade  was  observ ed in  adipo cytes der ived f ro m  
anim als su bm itt ed to a high -f at diet  feedin g acco m p an ied by  
en duran ce  tr a in in g.  The  lo west int er action  grade  was fo un d 
in  adipocytes from high-fat diet-fed animals (Figure  7). 
 
 
Discussion 
 
PTPIP51 prot ein  is exp ressed in adip o se tissue of h u m an , r at 
an d m o use.  On  the   basis  of  our  result s, we  co n clu de that 
PTPIP51 expression in mice  adipo se tissue is co rr elated to th e 
grade   of  in sulin r esist ance. Fast  recov ery of  bloo d gluco se 
after  glucose load  was asso ciat ed wit h h igh  PTPIP51  prot ein 
levels,  as seen  in  co ntrol an im als an d to  a so m ewh at  lo wer 
degree  in high -fat diet-f ed, tr ain ed an im als. In h igh-fat diet- 
fed  anim als, the   recovery  of  blo o d gl uco se  co n centr at io n s 
was extensively slowed down. 
High- f at diet-f ed an im als disp lay ed h yp ertrop hic  adip o-  
cytes,   as  seen   in  our   experim ent s and  reported before.24 
As suggested by  Kadowak i et al.,25  hypertrop hic adipocyt es 
are likely  to  develop insulin resistan ce. 
In sulin r esist an ce is asso ciat ed with a r educed t yro sin e 
ph o sp h ory latio n of the  IR.26  PTP1B is one  of the  crucial 
ph o sp hat ases r esp on sible for  the  deph o sp ho ry lat ion  of  th e  
IR. In our study, PTP1B mRNA was ex pressed in high  levels in 
adipo cyt es fro m h igh -f at diet-f ed an im als, wh ereas h igh- fat 
diet- f ed an d t ra in ed mice  display ed lo west levels.  Dif fer in g 
fro m  the  observ ed RNA levels,  PTP1B protein levels  were  th e  
same  in the  three ex p er im ental gro up s. Similar  result s co uld 
be  fo un d for  PTPIP51  mRNA  an d p rot ein.  The  mRNA  was 
high est in h igh -f at diet- f ed an im als an d lo w  in no rm al diet - 
fed anim als an d in an im als fed on high- f at diet  an d subject ed 
to   tra inin g.  The   p rot ein  levels   of  PTPIP51   were   h igh  in 
normal diet-fed animals and animals fed on high-fat diet  and 
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Figure 5   Duolink proximity ligation assa y f or P TPI P 51  and P TP 1B  in se cti o n s of  mouse adi p o se ti ssu e . Roll ing circle amplif ication (R C A ) t a ke s place if  both proteins 
are in cl o se proximity . The positiv e reaction is see n a s dots, indicating the position of both interacting proteins. (a) Standard-diet-f ed animal; (b) high-f at diet-f ed 
animal; (c) animal f ed on high-f at diet and subjected to training; (d) quantitativ e anal ysi s of  the interaction. Ordinate, dots per complete section an al ysi s; ar rows, 
nuclei stained with DAPI; arro w h e a d s, interaction between PTPIP51 and PTP1B. Bars, 50 mm. 
 
 
 
 
 
Figure 6   Immunostaining of  14-3-3b (a–c) and P TPIP 5 1 (d–f ). (a) 14-3-3b in adi p o se  ti ssu e  of  standard-diet-f ed animal; (b) 14-3-3b in a di p o se ti ssu e of  high-f at 
diet-f ed animal; (c) 14-3-3b in adipose ti ssu e  of  animal f ed on high-f at diet and subjected to training; (d) PTPI P5 1 in adipose ti ssu e of  standard-diet-f ed animal; 
(e) P TPI P 51  in a di p o se ti ssu e of  high-f at diet-f ed animal; (f ) PTPI P5 1 in a di p o se  ti ssu e  of  animal f ed on high-f at diet and subjected to training. Nuclei are  stai n e d  using 
DAPI. Arrows, co-localization of  14-3-3b and PTPIP51. Bar, 50 mm. 
 
 
 
subject ed to  tra inin g,  but  low  in  high -fat diet-f ed an im als. 
These  dif feren ces in  ex pression  levels  an d prot ein co uld be 
due  to  diff er ent p o sttr an slatio n al m o dificatio n or  stabiliza-  
t ion of the  mRNA. 
Our   exp er im ent s  r ev ealed a  co -localizatio n  of  PTPIP51 
wit h  PTP1B. Prev io us ex perim ents co nf irm ed an  int er act ion  
of PTPIP51  wit h PTP1B bot h in vitro an d in vivo.11  We  were 
also  able  to  verify  this  interactio n in  mouse adipocytes by 
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Figure 7   Duolink proximity  ligation assa y f or P TP IP 51 and 14-3-3b in sections of  mouse adipose tissue. Rolling circle amplif ication (R C A ) takes place if  both 
proteins are in cl o se proximity . The positiv e reaction is se en a s dots, indicating the position of both interacting proteins. (a) Standard-diet-f ed animal; (b) high-fat 
diet-f ed animal; (c) animal f ed on high-f at diet and subjected to training; (d) quantitativ e anal ysi s of  the interaction. Ordinate, dots per f ull section anal ysi s.  Arrows, 
nuclei are marked by  DAPI. Arrow h e ad s, interaction between PTPIP51 and 14-3-3b. Bars, 50 mm. 
 
 
 
the   DPLA.  Int erestin gly,  this   inter act io n  was  co rr ela t ed t o 
the  feedin g an d tr a in in g st at us of the  mice. High  int er act io n 
was seen  in norm al-f ed an im als an d was stro n gly r educe d in 
high -fat diet-f ed an im als.  Despit e  th eir  r ed uced con centr a-  
t io n of PTPIP51,  interact io n v alues seen  for high-f at diet- fed 
mice  subm itt ed to en duran ce t r ain in g cor r espo n ded to th o se 
observed in  control animals. 
In vario us tissues,  nam ely, m uscle an d liver,  PTP1B affects 
in sulin  sign alin g by  dep h o sph o ry latio n of  the  IR.7,8,2 6  T he 
role  of PTP1B in adipo se  tissue is less well st udied. Ov er-  
ex pression  of   PTP1B  in   adip o cytes  is  associated  with  a 
decrease in IR- an d IR sub st rat e-1-ph o sph ory lat io n,  a lth o u gh  
the  effect  of in sulin r em ain s ev ident. 27  Lack of PTP1B in  
adip o cyt es leads   to  increased ty ro sin e ph o sp ho ry lation   of 
the  IR and, thus, to  an  increase in  IR activity.28 , 29 
14-3-3b mediates  insulin  action  in   adipocytes30 ,31   by 
m o dify in g  the   Ras/Raf/MEK/ERK  path way,  wh ich  is 
import ant in   adipo cyte remodelin g and  different iation . 15 
Erk-1  activ atio n  is o bserv ed in  in sulin  sign alin g in  high -f at 
diet-f ed anim als.13  PTPIP51  can  affect  Raf1  act iv it y an d, in 
co n sequen ce,  r egulat e the  Ras/Raf/MEK/ERK  p at h way  by it s 
int er actio n wit h 14 -3 -3 b. 32  Two  co n serv ed prot ein do m ain s 
are   crucial  for   the   int er act ion   of   PTPIP51   an d  1 4-3-3 b, 
namely,  conserv ed  region  1  (CR1)- sp an nin g amino  acids 
43–48   and CR2  spann in g amino acids  146–154,32  leadin g 
to   the   observ ed hypertroph y  of  the   adipocyt es.  14-3-3b 
m ediat es effects  of the  in sulin sign alin g cascade.13, 30,3 1  Th us,  
PTPIP51  is  able   to  act   as  a  do wn str eam  r egulat or of  the 
insulin signalin g pathway via 14-3-3b. 
We  observed a stron g int eract io n of PTPIP51  an d 14 -3-3 b 
in train ed high -f at diet-f ed an im als, sug gest in g the  rev er sio n 
of insulin r esist an ce o bserv ed in an im als on  high-f at  diet  by 
the  en duran ce tr a in in g.  In  addit io n  to  that,  14 -3-3 b m RNA 
levels  were  very  high  in  an im als fed  on  high -f at diet  an d 
subject ed to  train in g, wh ereas no rm al-diet- f ed an d h igh- fat 
diet-fed animals display ed low  14-3-3b mRNA expressio n. 
The   energy status  of  adipocyt es is  regulat ed by  PKA .3 3 
Adren alin- in duced  l ip oly sis works  by  activ atio n  of the  PKA 
signalin g cascade. 34  Gluco se uptak e leads  to  the  activ atio n 
of  the   IR  an d to   the   reductio n  of  PKA  act iv it y, an d in 
con sequen ce  to  reduced PKA do wn st ream  sign alin g.35  T h e 
GP S  2.1  dat abase ident if ied PTPIP51  as  a  potentia l  inter- 
actio n  p art n er of P K A ,3 6  an d PTPIP51 is p ho sp h ory lated at its 
ser in e 212  residue by  PKA in  vitro.11  This  ph o sp h o ry latio n 
site is locat ed in pro xim it y of CR2 of PTPIP51.  Phosp ho - 
ser in e/t hreon ine-co nt ain in g  m otif s in  int er act ion  p art n er s 
of  14-3-3b  can   influen ce  the   bindin g  of  the   partners. 3 5 
Takin g t hese facts into  acco unt , we hyp othesize that PTPIP51 
is a shifter  bet ween  the  lipo ly sis- in ducin g PKA sign alin g 
p ath way  an d the  l ip o ly sis- inh ibit in g in sulin sign alin g 
p ath way.  P h o sp h orylat io n  at  the  serin e 212  resid ue m i gh t 
trigger the  bindin g of PTPIP51  to  14-3-3b. 
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Trainin g affects  adipo se tissue by  in creasin g lypo ly sis3 7, 3 8  
an d up reg ulat io n  of  cAMP-activat ed kinase  P K A .3 8  We 
o bserved in creased PTPIP51  expression  in  the  adip o se tissue 
of train ed, high -f at diet- fed m ice  co m p ared wit h un tr ain ed 
high -f at diet- fed mice  an d an elev at ed int eraction  of PTPIP51 
wit h  1 4-3 -3 b,  suggest in g  a  p o ssible  sh ift s to ward h igh er 
insulin sensitivity. 
Furth er  st udies  will   follo w  to   disclo se  the    co m plete 
function of PTPIP51  in  diabetes and obesity. 
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Abstract   Protein tyrosine phosphatase interacting protein 
51 (PTPIP51) interacts both in vit ro and in v ivo with 
PTP1B, a protein tyrosine phosphatase involved in cellular 
regulation. PTPIP51 is known to be expressed in many 
different types of tissues. It is involved in cellular processes 
such as proliferation, differentiat ion and apoptosis. Never- 
theless, the exact cellular function of PTPIP51 is still 
unknown. The present review summarizes our current 
knowledge of the PTPIP51 gene and its mRNA and  protein 
structure. 
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Introduction 
 
About 10 years ago, protein tyrosine phosphatase interact- 
ing protein 51 (PTPIP51) was discovered as an interacting 
partner o f protein ty rosine phosphatase 1B (PTP1B;  
Stenzinger et al. 2009b). Several publications have subse- 
quently dealt with its expression pattern in d iverse tissues 
from various animals. The init ial study revealed PTPIP51 to 
be expressed in epithelial cells of the epidermis, in ciliated 
cells of the trachea, in the fallopian tubes and in the 
ependyma of the brain ventricles. Reproductive tissue was 
also identified as expressing the PTPIP51 protein, PTPIP51 
being present in  primary spermatocytes with continuous 
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expression throughout differentiation up to the spermatid 
stage. Nervous tissue and skeletal muscle also show 
PTPIP51 protein expression, in the latter in  a fibre-type- 
specific manner. Additionally, PTPIP51 has been revealed 
to be expressed in every cell line investigated, e .g . 
glucagon-producing cells (INR1G9), human kerat inocytes 
(HaCat), human p lacental cells (BeWo), acetylcholine- 
producing cells (NS20Y) and Jurkat T-lymphoma cells 
(Stenzinger et al. 2005). Rat liver tissue exhib its the 
PTPIP51 antigen in a subset of hepatocyte nuclei, in 
cholangiocytes of the bile tract and in  non-parenchymal 
cells, namely  Kupffer cells, stellate cells and natural killer 
cells (Stenzinger et al. 2007). 
The expression pattern of PTPIP51 suggests its associ- 
ation with cellular processes such as proliferation and 
differentiation. Subsequent studies have identified PTPIP51 
protein as being involved in apoptosis and malignant 
transformation (Lv et  al. 2006; Koch et al. 2008). This 
multifunctional character of PTPIP51 protein raises the 
question as to how such a single p rotein  can fulfill 
opposing cellular functions. The present review combines 
the latest experimental knowledge with theoretical database 
informat ion and computational calculat ions regarding the 
PTPIP51 gene and its mRNA and protein structure and 
gives possible explanations for the mult itude of functions 
performed by  PTPIP51 with in the processes of prolifera- 
tion, differentiation and apoptosis. 
 
 
Present  experimental  data  concerning  PTPIP51 
 
Following the basic description of PTPIP51 expression by 
Stenzinger and co-workers (2005), subsequent studies 
aimed  to create a more detailed p icture o f its expression 
correlated to cellular function. Investigations of HaCat cells 
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treated with epidermal growth factor (EGF), transform- 
ing growth factor β, retino ic acid (RA) and 1,25- 
dihydroxyvitamin  D3  (vitamin  D3)  p rovided  the  first 
data concerning the functional involvement of PTPIP51 
in p rotein t ranslat ion (Stenzinger et al. 2006). PTPIP51 
expression was found to be influenced by these growth 
factors. HaCat cells in it ially d isplayed  a decrease in  
PTPIP51-positive cells treated with a low concentration  
of EGF (10-9  M) fo llowed by a step-wise up-regu lation  
with h igher concent rat ions o f EGF (10-7  M). The 
different iat ion-inducing vitamin D3 stimulated PTPIP51 
protein expression and augmented the number of PTPIP51- 
positive HaCat cells. RA had no effect on the number of 
PTPIP51-positive cells when used at physiological concen- 
trations. Exposure of cells to a supr ap hysiologic al  concentra- 
tion of RA (10-5  M) resulted in a dramatic increase of 
PTPIP51-positive cells. Based on these findings, Barop and 
co-workers (2009) probed cultured human muscle cells for 
PTPIP51 protein hoping to corroborate the hypothesis that 
PTPIP51 is involved in differentiation processes. When 
differentiating into multinucleated myotubes, cultured myo- 
blasts displayed an up-regulat ion of PTPIP51 mRNA 
expression. Exposure of the differentiated myotubes to 
proliferation-promoting conditions resulted in a sharp drop 
in PTPIP51 mRNA expression. Nev erthel ess,  in both studies, 
the investigated cell lines always displayed a basic expres- 
sion of PTPIP51 during the proliferation state. 
The haematopoietic system is characterized by a high 
turnover of cells, which  subsequently undergo terminal 
differentiation. In  healthy bone marrow trephine specimens, 
PTPIP51 is neither associated with proliferating cells nor 
with  apoptotic cells. PTPIP51 protein is restricted to the 
myeloid lineage. Furthermore, mature neutrophil granulo- 
cytes of bone marrow t rephine specimens, umbilical cord 
blood and peripheral venous blood contain large amounts 
of PTPIP51 protein (Brobeil et al. 2010). Tyrosine kinases 
mediate the signals of various haematopoietic cytokines 
(Miranda and Johnson 2007). The signal transduction is 
controlled by distinct protein tyrosine phosphatases such as 
PTP1B  (Heinonen  and  Tremblay  2006;  Barreda  et  al. 
2004). As PTPIP51 and PTP1B interact in neutrophil 
granulocytes of umbilical cord blood and peripheral venous 
blood, a signal transducing function of PTPIP51 can be 
assumed (Brobeil et al. 2010). Moreover, Bobrich and co- 
workers have confirmed the interaction of PTPIP51 and 
PTP1B in mice adipose tissue (Bobrich et al. 2011). 
Apart from this, the PTPIP51 protein, if over e xp r ess ed  in  
HEK293T and in HeLa cells, is connected to the apoptotic 
mach inery (Lv et al. 2006). Hallmarks of apoptosis are 
divided into morphological and biochemical alterations. 
Cell shrinkage, chromat in condensation and cell fragmen- 
tation into small vesicles are typical morphological charac- 
teristics for apoptotic cells. In biochemical terms, apoptosis 
is characterized by DNA degradation through endogenous 
DNases, the activation of caspases and the depolarizat ion of 
the mitochondrial membrane with the subsequent release of 
pro-apoptotic factors (Saraste and Pulkki 2000; Ly et al. 
2003). These processes have also been observed when 
PTPIP51 is overexpressed in HEK293T cells. After 
transfection, a significant increase in the active caspase 3 
and its substrate poly ADP ribose polymerase is detected 
(Lv et al. 2006). Moreover, the membrane potential of the 
mitochondria is reduced and cytochrome c is released. 
Thus, PTPIP51-t ransfected cells with  subsequent over- 
expression display all the features of apoptosis. Interesting- 
ly, PTPIP51 protein contains a transmembrane domain 
(TMD) that is essential for its translocation to mitochondria 
and the induction of apoptosis. This association of PTPIP51 
with apoptotic processes has also been observed in vivo; 
however, a restriction solely to apoptotic functions has been 
excluded (Stenzinger et al. 2009a; Maerker et al. 2008). 
Apoptotic cell death is crucial fo r the normal develop- 
ment of various organs such as the retina (Linden et al. 
2005). The screening of embryonic tissue samples at 
various stages of murine eye development has stressed the 
importance of PTPIP51 expression during the maturation of 
this organ (Maerker et al. 2008). Apoptotic cells labelled by 
the TdT-mediated dUTP-b iotin n ick-end labelling assay 
display no exclusive association with the PTPIP51 protein. 
On  the contrary, not all PTPIP51-positive cells undergo 
apoptosis. 
During retinal differentiat ion, PTPIP51 expression is 
down-regulated by the ciliary neurotophic factor (CNTF; 
Roger et al. 2007). CNTF has neuroprotective effects and 
can prevent neurons from degenerating in  diseases such as 
H u nt ingt on’s (de Almeida et al. 2001). Hence, PTPIP51 
down-regulation mediated through CNTF is probably a 
regulatory mechanis m to adjust the pro-apoptotic effect of 
PTPIP51 in a cell-specific manner contributing  to the 
differentiation process. 
Summarizing these find ings, we postulate that the 
PTPIP51 protein is regulated through growth factors and 
cytokines that thereby adapt the expression of PTPIP51 to 
cellu lar requ irements such as proliferat ion, d ifferentiation 
or apoptosis. 
In a systemat ic morphological study, the PTPIP51 
protein was found to be restricted to specific areas and 
nuclei o f the mouse brain . Neurons were labeled  with 
antibodies against the PTPIP51 antigen, whereas glial cells 
remained unstained (Koch et al. 2009b). In malignant 
transformation  such as glioblastoma, however, glial cells 
started to express PTPIP51 (M. Pet ri, P. Koch , A. 
Stenzinger, K. Kuchelmeister, U. Nestler, K. Steger, M. 
Viard, M. Wimmer, in preparation). 
Such a correlation of PTPIP51 protein expression and 
malignant transformation was also confirmed for various 
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skin carcinomas such as basal cell carcinomas (BCC), 
squamous cell carcinomas (SCC), Bo w e n’s disease and 
keratoacanthomas (Koch et al. 2008). Malignant cells of 
BCC and SCC showed a co-lo cal iz at ion  o f PTPIP51 and β- 
catenin. Dysregu lated  β-caten in signalling was found 
with in various cancer types such  as colon ic cancer, 
melanoma and prostate cancer (Morin  1999). PTPIP51 
expression in colon ic cancer and melanoma is being 
confirmed by ongoing studies in our laboratory. In  addition, 
breast cancer samples of ductal and lobular orig in display a 
variable expression pattern of PTPIP51. A recent study has 
shed light on PTPIP51 expression in prostate cancer (Koch 
et  al.  2009a;   see  also  below).  In  addit ion  to  occurring 
with in solid tumours, the PTPIP51 protein has also been 
traced in a malignant transformed myeloid cell in acute 
myelo id leukemia (AML). PTPIP51 expression is not 
correlated with  the subtype of AML as classified  by the 
French-American-British system (A. Brobeil, M. Bobrich , 
M. Graf, A. Kruchten, W. Blau, M. Rummel, S. Oeschger, 
K. Steger, M. Wimmer, in preparation). 
However, the exact cellular function of PTPIP51 is still 
unknown. Recent studies on the impact of PTPIP51 on 
signalling pathways have identified PTPIP51 as being 
involved in the mitogen-activated protein kinase (MAPK) 
pathway (Yu et al. 2008;  Bobrich et al. 2011). Yu and co- 
workers (2008) have shown that PTPIP51 is capable of 
increas ing ERK act ivat ion  by interact ing with Raf-1 
through 14-3-3 proteins. Consequently, the  cells display 
an elongated cell morphology and increased cell migration, 
adhesion and spreading. The down-regulation of PTPIP51 
abrogates these effects. Apart from its effect on cellular 
morphology and cell migration, PTPIP51 interacts with 14- 
3-3beta in ad ipocytes of specifically fed and  trained mice, 
as verified in vivo by duolink proximity ligation  assay 
(DPLA). The punctate pattern  of the hybridized and 
amplified antibody-linked nucleotide strands for PTPIP51 
and the investigated interaction partner is only apparent 
when both proteins are in closest proximity. Strikingly, the 
high-fat diet trained mice d isplay the highest grade of 
interaction compared  with high-fat  diet mice or control 
mice. Recent studies (to be published) have revealed an up- 
regulation of the insulin receptor mRNA in h igh-fat diet 
trained mice. 14-3-3 proteins are known to mediate the 
insulin  signal  (Xiang et  al.  2002;  Onuma  et   al.  2002). 
Under these cond it ions, PTPIP51 expression is up- 
regulated because of the increased demand for the linker 
partner. Furthermore, PTPIP51 acts as a cross-linking 
molecu le  with in  the  c-Kit  signalling  pathway  in  cells 
of AML bone marrow trephine biopsy specimens (A. 
Brobeil, M. Bobrich, M. Graf, A. Kruchten, W. Blau, M. 
Rummel, S. Oeschger, K. Steger, M. Wimmer, in prepara- 
tion). Two Src kinases, namely c-Src and Lyn, phosphor- 
ylate PTPIP51 at its tyrosine residue 176. In AML blasts, 
the entire PTPIP51 protein is nearly completely phosphor- 
ylated at tyrosine 176. Probing AML samples by DPLA has 
shown that PTPIP51 has no effect on MAPK pathway 
regulation. The phosphorylation of crit ical tyrosine residues 
might be a regulatory mechanis m controlling the effect of 
PTPIP51 on the MAPK pathway (see below). 
These experimental data stress the functional involve- 
ment of PTPIP51 in proliferation, differentiat ion, apoptosis 
and malignant t ra nsf or m at io n. In the following sections, the 
experimental findings are discussed in relation to theoret- 
ical considerat ions gained by database searches and 
computational calculations, thus extending the knowledge 
of the function of PTPIP51. 
 
 
PTPIP51  gene: structure and mechanisms of regulation 
 
The PTPIP51 gene is located on the minus strand of human 
chromosome 15 (15q15.1, position 41,028,086-41,047,458) 
encompassing 13 exons and having a length of 19,373 base 
pairs (bp). Up to now, the nomenclature for the PTPIP51 
gene has been inconsistent. The gene belongs to the family 
with sequence similarity 82 (FAM82). The gene family is 
subdivided into three groups, named alphabetically with A, 
B and C. PTPIP51 is a member of subclass C, wherefore 
the PTPIP51 gene is named FAM82C. Alternatively, the 
FAM82 members are categorized solely into groups A and 
B. In this case, the PTPIP51 gene can be identified as 
FAM82A2. Th is nomenclature of the PTPIP51 gene was 
established in the 17th revision of the human genome in 
March 2006. Prior to that, the PTPIP51 gene and its protein 
were known as FLJ10579. 
Apart from this basic information, little is known about 
the PTPIP51 gene and its regulation. A  recent study has 
provided crit ical new insights into the regulation of the 
PTPIP51 gene by investigating the methylation status of the 
gene promoters (Koch et al 2009a). The investigated CpG- 
rich promoter region is located on intron 2 at  position 793 
to 1112 (Fig. 1b). Another predicted CpG-rich island  is 
located ahead of exon 1 (Fig. 1a). Th is island is probably 
the main in itiat ion site for transcription attributable to the 
full transcription of the PTPIP51 gene. Figure 1c, d g ives 
an overv iew of the promoter locat ion and pred icted  
transcription factors (Tr ans c ript ion Element Search System, 
http://www.cbil.upenn.edu/cgi-bin/tess/tess). 
DNA methylation stabilizes the chromatin  structure and 
is crucial to epigenet ic gene regu lat ion in mammals 
(Shames et al. 2007). Gene silencing is achieved by the 
methylat ion of CpG-rich islands associated with gene 
promoters thereby  inhib it ing the b ind ing of relevant 
transcription factors. Demethylation leads to the opposite 
effect: cells display increased transcription and translation 
of demethylated genes and their products (Ellis et al. 2009). 
 
 
 
  
Cell T issue Res 
 
 
 
Fig. 1 The protein tyrosine phosphatase interacting protein 51 
(PTPIP51) gene has two Cp G-rich islands, which resemble possible  
promoter regions. These CpG-rich islands can be methylated and 
silenced, preventing transcription. a Potential PTPIP51 promoter 
region located in front of exon 1. b PTPIP51 promoter sequence 
includin g the investigated CpG-rich island. c Location of the two 
promoters (PROM1, PROM2) of  the PTPIP51 gene. d  Calculated 
transcription factors binding  to  the  promoters (MYOG myogenin, 
CTCF CCCTC-bin ding  factor  [zinc  finger  protein],  NF-1 nuclear  
factor 1, GCF  GC-bindin g factor, ER α oestrogen receptor alpha, AP-1 
activator protein 1, TCF T-cell factor). e Quantitative reverse 
transcription with the polymerase chain reaction of samples of benign  
prostate hyperplasia (BPH ) an d prostate carcinoma (PCA ).  f Promoter 
methylation of the promoter region 2 of the PTPIP51 gene in prostate 
cancer (PC a ). g Promoter methylation of the promoter region 2 of the 
PTPIP51 gene in benign prostate hyperplasia (BPH) 
 
 
 
Koch and co-workers (2009a) have linked the overexpres- 
sion of the PTPIP51 protein to the methylation status of the 
PTPIP51 gene in prostate cancer. In benign p rostate 
hyperplasia, eighteen investigated CpG-rich regions are 
hypermethylated compared with their methylat ion status in 
prostate cancer (Fig. 1f, g). 
Glial cells from mouse brain samples show no transcrip- 
tion of the PTPIP51 protein (Koch et al. 2009b). Interest- 
ingly, in g lioblastoma, malignant transformed  glial cells 
exhibit  PTPIP51 expression. Two changes are known to 
occur with regard to DNA methylat ion status during 
carcinogenesis: genome-wide hypomethylation and dysre- 
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gulation of the methylation status at distinct CpG-rich 
promoters (Shames et al. 2007). Thus, promoter methyla- 
tion might be one mechanism of PTPIP51 gene regulat ion. 
Subsequent studies are needed to correlate the promoter 
methylation status to diseased and healthy tissue. 
As genes are regulated multifactorially, we performed 
database searches for other regulatory mechanisms. The 
cAMP-response element binding protein (CREB) target 
gene  database (http://natural.salk.edu/CREB/) added  evi- 
dence that the PTPIP51 gene has a cAMP-response element 
(CRE) with the full site sequence (TGACGTCA). Prelim- 
inary experiments revealing the presence of a CRE were 
pe rfo r m ed.  Us ing a chromatin immunoprecip itation-on-chip 
(ChIP-ch ip), CREB and phosphorylated CREB were shown 
to bind to the promoter region of the PTPIP51 gene. Two 
values were provided by the study: the confidence level of 
the binding (P-value) and the ratio of ChIP signal over 
control genomic DNA (binding ratio). The recommended 
cut-off values for ChIP-positive gene were P<0.001 and  a 
binding ratio of >2. The obtained values were highly 
significant except for islet cells, according to the recom- 
mended cut-off values. Furthermore, CREB and phosphor- 
ylated CREB b inding was shown to increase with exposing 
time to the protein kinase A activator forskolin in the 
HEK293T cell line (Zhang et al. 2005). Various signalling 
pathways were shown to activate CREB by phosphoryla- 
tion at serine 133. In addition to protein kinase A and the 
Ca2+/calmodulin-dependent  protein  kinases,  the  MAPK 
pathway is capable of activating CREB by  phosphorylation 
mediated through p90 ribosomal S6 kinase (p90RSK; 
Shaywitz and  Greenberg 1999;  McCubrey et  al.  2000). 
The archetype of the MAPK pathway activating receptor is 
the EGF receptor (EFGR). Activation of the EGFR by its 
main ligand, viz. EGF, leads to cell pro liferat ion paralleled 
by the activation of the MAPK pathway and CREB. 
Immortalized human kerat inocyte cancer cells (HaCat) 
exposed to EGF show a concentration-dependent up- 
regulation of PTPIP51 expression (Stenzinger et al. 2006). 
Subsequent in vivo studies are crucial to ascertain PTPIP51 
gene regulation by a CRE but the theoretical information 
related to experiments hints at the presence of a CRE near 
its gene locus. 
Moreover, glioblastoma cells express a mutant of the 
EGFR. Th is EGFR variant III enhances the tumourigenic 
potential by act ivating and sustaining mitogenic, anti- 
apoptotic and pro-invasive signalling pathways (Gan et al. 
2009). The constitut ive signal might enhance CREB 
phosphorylation with the subsequent up-regulat ion o f 
PTPIP51. This  suggests the existence of an additional 
mechanis m for PTPIP51 expression in transformed glioma 
cells. 
Roger et al. (2007) have identified CNTF as down- 
regulating PTPIP51 gene  expression in  retinal explants. 
CREB activation is reduced in retinal explants of wild-type 
mice subjected to CNTF and brain-derived neurotrophic 
factor (Azad i et al. 2007). Thus, decreased PTPIP51 
expression correlates with lower amounts of active CREB. 
In summary, the PTPIP51 gene is assumed to be 
regulated by at least two mechanis ms: on the one hand, 
the methylation and demethylat ion of critical CpG-rich 
residues in the promoter reg ions of the PTPIP51 gene and, 
on the other hand, the CRE-controlled transcription. 
 
 
PTPIP51  mRNA: structure, post-transcriptional 
processing and protein  translation 
 
The mRNA sequence (National Center for Biotechnology 
Informat ion [NCBI] Reference Sequence database acces- 
sion  code  NM_018145) consists in  2251  bp  distributed 
over 13 exons, whereby exon 1 is a non-coding exon. Exon 
1 forms the 5′ untranslated region (5′-UTR) o f PTPIP51 
mRNA. 
Exon 13 encompasses 707 bp but only the first 51 bp 
en cod e  for amin o  a cids  454 to 470 of the PTPIP51  protein. The 
triplet on exon 13 at position 1596 resembles the stop-codon- 
related sequence UAA and terminate s protein synthesis. 
For the init iation of t ranscription, an AUG trip let is 
required with a specific surrounding sequence. The optimal 
consensus sequence has been iden t ified as fo llows : 
GCCRCCaugG (R stands for purine bases). Positions -3 
and +4 play key roles for the strength of initiation (Kozak 
2005). Strikingly, the first AUG t rip let is located on exon 1, 
which  does not code for the PTPIP51 protein. The 
surrounding bases are in accordance with the optimal 
consensus sequence for the initiation of translation. Anal- 
ysis of the full mRNA sequence of PTPIP51 by an  open 
reading frame (ORF) finder (http://www.bot.uni-heidelberg. 
de/sms/javascript/orf_find.html) identifies  five  ORFs  by 
using AUG as the exclusive start codon, reading frame 3 
on the direct strand and a min imum ORF length of four 
codons. The first ORF is located at position 45 to 47 of the 
PTPIP51 mRNA. The coding mRNA sequence ends after 
nine codons with a stop codon at position 72 to 74. The 
following ORF from base 186 to base 1598 encompasses 
the coding sequence for the PTPIP51 fu ll-length protein 
(Fig. 2a). Hence, the upstream ORF (upORF) might serve 
as a regu lator for the translation of the PTPIP51 protein. 
This mechanis m has been observed for several mRNAs 
(Kozak 2005). The PTPIP51 mRNA structure including 
upORF can also be traced in other mammals and thus 
evolut ionary  conservat ion  can be assumed. PTPIP51 
mRNAs of mouse and rat exh ib it an upORF that differs 
in its localization compared with the human PTPIP51 
mRNA. The upORF overlaps the protein coding ORF 
resulting in  a  low  level  of  PTPIP51 protein translation 
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Fig. 2  PTPIP51 mRNA exhibits a regulatory upstream open reading 
frame  (upORF). The  upORF  is  conserved  bet ween  the  three 
investigated species. a  Location of the upORF in human PTPIP51 
mRNA. b The upORF of rats shows an overlap with the main open 
reading frame (ORF). c PTPIP51 mRNA of mice exhibit  an 
overlapping upORF with the main ORF 
 
 
(Fig. 2b, c). Such strict regulation  of mRNA translation is 
mainly  observed fo r g rowth  facto rs and other proto - 
oncogenes (Kotechov 2008). The express ion of the 
PTPIP51 protein and mRNA in human  skeletal muscle cell 
lines is differentiation-dependent. Undifferentiated myo- 
blasts show both low mRNA and protein levels of 
PTPIP51. Differentiation into multinucleated myotubes 
results in a linear increase of PTPIP51 protein  levels 
proceeded by an intense increase of PTPIP51 mRNA 
expression (Barop et al. 2009). UpORF repression of 
translation is unlikely. However, in cases of reaching a 
critical protein  level that could induce apoptosis, upORF 
might sustain the mRNA/protein ratio by limit ing the 
translation of PTPIP51 mRNA. Interestingly, the transcript  
starting at the alternative promoter of the PTPIP51 gene 
lacks exon 1 and thus the upORF. This leads to the 
translation of the full-length protein without any control of 
the protein expression by an upORF. The observed over- 
expression of the PTPIP51 protein in  prostate cancer 
corroborates this hypothesis. In benign prostate hyperplasia 
and in prostate cancer, PTPIP51 mRNA has been observed 
to be expressed in the same amounts by quantitative 
re ve rse -t ra ns cript ase po lymerase chain reaction (qRT-PCR) 
experiments (Fig . 1e). Compared  with benign prostate 
hyperp lasia , the alternat ive p romoter is found to be 
hypomethylated in prostate cancer (Fig. 1f, g; Koch et al. 
2009a). DNA and promoter methylation is one reason for 
switching from the core-promoter to an  alternative promoter 
(Davuluri et al. 2008). The new transcript lacks the upORF 
resulting  in  an  overexpression  of  PTPIP51.  Thus,  we 
hypothesize that promoter switching and the multiple start 
codons are a cancer-dependent mechanism for the dysregu- 
lation of both PTPIP51 mRNA transcription and translation 
leading to independent growth and proliferation. 
The full translation of PTPIP51 mRNA results in a 
protein product of 52 kDa. This protein corresponds to the 
full-length form of PTPIP51. As listed in Table 1, immu- 
noblotting of various tissues displays different PTPIP51 
levels with isoforms of variable molecular weights. Hither- 
to, no study has analysed the underlying mechanism of 
PTPIP51 isoform synthesis and no experimental data have 
verified the existence of isoforms at the mRNA level. 
Experimental findings are limited to Western blot analyses. 
Nevertheless, two theoretical mechanis ms exp lain ing the 
expression of PTPIP51 protein isoforms are discussed here. 
The molecular weights obtained by Western blot analyses 
have been correlated to hypothetical database information 
and computational calculat ions: one probable mechanis m is 
the use of different initiat ion-sites on PTPIP51 mRNA for 
translation. The scanning of the coding ORF for internal 
start codons has led to six addit ional AUG triplets being 
found at positions 375 to 377, 573 to 575, 804 to 806, 1044 
to 1046, 1275 to 1277 and 1506 to 1508 corresponding to 
exon 3, 4, 5, 6, 9 and 12, respectively. These alternative 
initiation codons result in expected molecular weights of 
45 kDa, 38 kDa and 30 kDa (Prote inC a lcu lato r v3.3, http:// 
www .sc rip p s.e d u/∼c dp utn a m /p rotc a lc .h tm l;   Stenzinger  et 
al. 2005). The underlying mechanis m is called leaky 
scanning.  Optimal sequences border the AUG triplet and 
are recognized by ribosomes as translational initiat ion site 
(TIS). AUG t rip lets lacking this consensus sequence are 
reduced in their ability to start translation. Thus, a subset of 
ribosomes misses the start codon and continues scanning 
downstream until it recognizes an alternative AUG trip let. 
This mechanis m allows the ribosomes to detect different 
TIS within  the ORF lead ing to distinct isoforms of the 
protein.  The  resu lt ing  products  are  t runcated  at  the 
N-terminal end (Kochetov 2008). 
The first and second alternat ive AUG trip lets marking 
the start of PTPIP51 protein  translat ion are not in 
accordance with the optimal consensus. In contrast, the 
third alternative start codon is bordered by an adenosine 
at position -3 and a guanine at position +4. This is an 
optimal context for t ranslation in itiation. Thus, PTPIP51 
isoforms with molecular weights lower than 30 kDa are 
unlikely to  be t rans lated exclusively by  the leaky 
scanning mechanism. 
Immunoblot  analyses  corroborate  the  expression  of 
PTPIP51  isoforms  with  molecular  weights  of  30,  45, 
52 kDa, e.g. in isolated neutrophil granulocytes of peripheral 
venous blood (Table 1). The 38-kDa isoform is known and 
assigned under Q96TC7-2 in the Uniprot database. More- 
over, the 45-kDa and 30-kDa isoform are listed in the NCBI 
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Table  1  Molecular weights of 
PTPIP51 isoforms revealed by 
immunoblotting 
T issue Origin PTPIP51 isforms [kDa] 
Acute myeloid leukmia Human 52, 38.25,13 
Embryonic tissue 12day: 75,60,30 
13day: 100,75,60,48,35,30 
14day: 100,75,60,48,35,30 
Adult eye Human 28 
Brain Mouse Hippocampus: 45,38,37,35 
Cortex: 150,65,52,48,33,30,27 
Cerebellum: 150,120,100,75,52,48,35,33,30,27 
Skeletal muscle Rat 40,25 
Skeletal muscle cell line Human 0day: 60,48 
13day: 80,60,48 
13da y + 10: 60-48 
Trachea Rat 65,36 
Jurkat Human 75,52,48,38 
HaCat Human 120,100,68,52,48,38,35,33,25,17, 
Blood Human 65,52,45,38 
Testis Rat 48 
Sperm Human 37 
Placenta Human 52,45,38,35,28 
Spinal cord Human 40 
Liver Tat 75,52,33,27 
 
 
protein database under accession numbers BAG53446 and 
BAB15298, respectively. 
Nevertheless, some of the observed isoforms cannot be 
explained by leaky scanning suggesting a second mecha- 
nism: alternative splicing is another possibility for aug- 
menting the number o f PTPIP51 isoforms. Proteomic 
diversity in multicellular eukaryotes is based mainly on 
alternative splicing (Nilsen and Gravely 2010). Recent 
studies report that almost 95%–100% of p re-mRNAs 
transcribed from multi-exon genes are alternatively spliced 
(Nilsen and Graveley 2010). PTPIP51 mRNA exhibits 13 
exons and is therefore highly likely to be alternatively 
spliced. Alternative splicing occurs in a developmentally, 
different iat ion and even s ignal-transduction-dependent 
manner (Sánchez 2008;  Calarco et al. 2009;  Lynch 2007). 
Up to  now, experimental data corroborating the presence of 
alternatively spliced transcripts are missing. However, the 
theoretical alternative splicing prediction (ASPic, http:// 
t.caspur.it/ASPIC/index.php, Bonizzoni et al. 2005) web- 
tool calculates 24 alternative spliced mRNAs for PTPIP51 
(Fig. 3a). As has been shown recently, the prediction is 
reliable, e.g. the predicted alternat ively  spliced transcripts 
of the mitochondrial transcription factor A  have all been 
corroborated by RT-PCR (De Virg ilio et al. 2011). In the 
alternative splicing and transcript diversity (ASTD) data- 
base (ht tp:/ /w w w. e bi .a c. uk/ astd/m ain. ht ml)  o f the European 
Bioinfor mat ics  Inst itute (EBI) a splice variant of PTP IP5 1 has 
been assigne d the identi fic atio n numbe r TRAN00000049919. 
The splice variant codes for 107 amino acids (aas) of the 
C-terminus of PTPIP51 (PEP T 00 000 03 90 18). This variant is 
also a predict ed  spliced product listed by the ASPic web-tool. 
Hence, the observed alternatively spliced variant expression 
and the predicted spliced variants support the hypothesis that 
PTP IP5 1 mR N A  is al ternat ively spl iced . In a ddi t ion, PTPIP51 
isoforms are also expressed depending on the differentiation 
status and origin o f the cel l . In huma n ne ut rophi l  granulocytes, 
PTPIP51 is expressed with molecular weights of 30, 38, 45 
and 52 kDa. As shown by qRT-PCR with exon-specific 
primers for PTPIP51 mRNA detection, PTPIP51 exons are 
expressed in similar amounts making alternative splicing 
unl ikely (F ig. 3b). Thus, in neutrophil gra nulo cytes,  the leaky 
scanning mechanism is probably responsible for PTPIP51 
isoform production. To confirm this, qRT-PCR experiments 
covering all exons are needed. Furthermore, the assembled 
cDNA has to be sequenced. Other t issues exh ib it  a 
heterogeneous mix of PTPIP51 isoforms with  variab le 
molecular weights (Table 1). Here, alternative splicing might 
play an important role in the expression of specific PTPIP51 
isoforms for the mainten an c e o f its various cellular functions. 
Further qRT-PCR experiments covering all exons of 
PTPIP51 might shed light on alternative splicing processes 
concerning PTPIP51 mRNA. 
These findings indicate that PTPIP51 protein translation 
is strict ly controlled, by the inhibit ion of overexpression, in 
order to prevent subsequent cell dysfunction. Alternative 
AUG triplets serving as start codons enable the expression 
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Fig.  3  PTPIP51  mRNA  con- 
sists in 13 exons, which are 
likely to be processed by alter- 
native splicing. a The alternative 
splicing prediction server 
(ASPic, http://t .caspur.it/ASPIC/ 
index.php, Bonizzoni et  al. 
2005) calculated 24 possible 
splice variants (UTR 
untranslated region, CDS coding 
sequence, PTC premature 
termination codon, chr chromo- 
some). The overview illustrates 
their structures (image source: 
http://t .caspur.it/ASPIC/tmp/ 
trans_list874_job1221.png) b 
qRT-PCR of isolated neutrophil 
granulocytes by using exon- 
specific primer. 1 = sample 1; 
2 = sample 2 
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of various isoforms. Alternative splicing  is a second 
mechanis m used to enhance the cellular adapted expression 
of PTPIP51 isoforms. We hypothesize that both mecha- 
nisms can occur singularly or in  combination, depending on 
the investigated tissue or cells. 
 
 
PTPIP51  protein:  isoforms exhibit functional  adapted 
domains 
 
As shown by various studies, the PTPIP51 protein is 
associated with proliferation, differentiat ion and apoptosis 
(Barop et al. 2009; Koch et al. 2008; Lv et al. 2006). To 
date, the protein structure of PTPIP51 is unclear. Therefore, 
a predicted model of PTPIP51 protein structure has been 
generated by the I-TASSER server (http://zhanglab.ccmb. 
m ed. u mic h. ed u/ I- TAS S ER/;  Roy et al. 2010). The predicted 
protein structure and surface are presented in Fig. 4a, b. 
T h e   P T P I P 5 1   p r o t ein  b e l o n gs   to  a   f a m i l y  o f 
microtubule-associated proteins called regulators of micro - 
tubule dynamics (RMD). The human family consists in 
three members, which are consecutively numbered. The 
alternative name for PTPIP51 is human RMD-3 (hRMD-3; 
Uniprot accession no. Q96TC7). Oishi and co-workers 
(2007) have cosedimented PTPIP51 associated to taxol- 
stabilized microtubu les. In interphase cells, PTPIP51 
protein is found within  defined spots throughout the 
cytoplasm, whereas in mitotic cells, PTPIP51 is trans- 
located to the spindle apparatus (own observations; Oishi et 
al. 2007 supplement). As indicated in  Fig. 5a, the sequences 
of RMD-1 and PTPIP51 both show conserved regions. The 
tetratricopeptide repeat (TPR) domains of RMD-1 marked 
by a line spanning the relevant protein sequence (Fig. 5a) 
are also present within the PTPIP51 protein. Furthermore, 
 
 
 
 
Fig. 4  The tertiary protein structure of PTPIP51 is unknown. The 
I-Tasser server (http :// zh a ngl a b .c c m b. m e d.u m ic h. ed u/I - TA S S E R /; Roy  
et al. 2010) predicts a possible structure of the PTPIP51 protein. a 
Ribbon structure of PTPIP51 (ye llow  transmembrane domain, purple 
coiled-coil, blue conserved domains 1 and 2, cyan tetratricopeptide- 
like domain, red known serine phosphorylation residues, green known 
tyrosine phosphorylation residues). b Calculated surface of the 
PTPIP51 protein model 
PTPIP51 is known to encompass a TPR-like domain 
spanning aa303 to aa447. Leaky scanning has found all 
PTPIP51 isoforms containing the TPR-like domain. An 
example of this is shown for the full-length protein and the 
38-kDa isoform in Fig. 5b-e. A subset of alternatively 
spliced isofoms of PTPIP51 lacks  this domain. First, the 
TPR domain  is associated with the cell cycle (Sikorsky et 
al. 1990). The two  mic ro tubu le-as sociated p ro teins 
PTPIP51 and RMD-1 are recruited to the spindle apparatus 
during mitosis and RMD-1 is known to be crucial for 
normal kinetochore binding of spindle microtubules (Oishi 
et al. 2007). Interestingly, the proteins most important for 
mitosis contain several TPR domains (Goebl and Yanagida 
1991). Moreover, PTPIP51 protein has been found to 
interact  with  the  kinetochore  protein  Nuf2  in  vivo  by  
DPLA (A. Brobeil, M. Bobrich, M. Wimmer, in prepara- 
tion). The human Nuf2 (hNuf2) protein has been shown 
to be associated  with the outer kinetochore p late. 
Addit ional short interfering RNA experiments have 
corroborated the stab ilizing funct ion  in microtubu le 
attachment to the kinetochore. hNuf2 is a  co iled-co il 
protein (DeLuca et al. 2002) and acts as a linker between  
the plus end of the microtubules and the kinetochore. 
Various co iled-co il p roteins are associated with the 
kinetochore, such as mitosin, cent romere protein F o r 
centromere/kinetochore protein ZW10 (Rose and  Meier 
2004). Thus, PTPIP51 is high ly likely to fo rm a complex 
with hNuf2 during mitosis. We can therefore assume that 
PTPIP51 is involved in mitotic processes such as the 
regulat ion of the spind le apparatus and accurate chromo- 
some segregation. 
The centrosome is an essential part for the formation of 
the mitotic spindle apparatus. In addition, the centrosome is 
the microtubule-organizat ion centre of the cell and nucle- 
ates the microtubules (Rieder et  al. 2001). The centrosome 
is formed  by two centrioles, which are sourrounded by the 
pericentrio lar matrix (PCM). Human n inein (hNinein) is 
one com pon e nt  o f the PCM and possibly stabi lizes  the linkage 
between the microtubules and the centrioles (Delgehyr et al. 
2005). In a yeast two-hybrid screen, CGI-99 (alternatively 
C14orf166) has been identified as an interaction partner of 
hNinein, which is associated with the centrosome. Interest- 
ingly,  CGI-99  is  able  to  inhibit  the  phosphorylation of 
 
 
Fig. 5  PTPIP51 is also known as a regulator of microtubule dynam ic s„ 
3 (RMD-3) and belongs to a new family of microtubule-associated 
proteins. PTPIP51 and RMD-1 exhibit sequence homologies. Both 
proteins contain a  tetratricopeptide-like domain and  PTPIP51 pos- 
sesses an additional coiled-coil domain. a  Sequence alignment of 
PTPIP51 and RMD-1. b PTPIP51 full-length protein (52 kDa) with its 
coiled-coiled  and  tetratricopeptide-like domains.  c  The  PTPIP51 
38-kDa isoform exclusively exhibits the tetr atri c op ep tid e -lik e domain. 
d Tertiary structure of PTPIP51 coiled-coil domain. e Tertiary 
structure of PTPIP51 tetratr ic op ep tid e- lik e domain 
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hNinein mediated by glycogen synthase kinase 3 beta and 
therefore influences the nucleation of the microtubules 
(Howng et al. 2004). The direct interaction of PTPIP51 and 
CGI-99 has been revealed  by co-immunoprecipitat ion 
experiments and in vivo  by DPLA (A. Brobeil, M. Bobrich, 
M. Wimmer, in  preparation). Furthermore, during mitosis, 
PTPIP51 is also located at the spindle body suggesting the 
format ion of a complex with CGI-99 that regulates hNinein 
phosphorylation. CGI-99 is strikingly overexpressed in 
various brain tumours such as astrocytomas (Hwong et al. 
2004). Data obtained in our laboratory confirm that PTPIP51 
is expressed in malignantly transformed glial cells (M. Petri, 
P. Koch, A. Stenzinger, K. Kuchelmeister, U. Nestler, K. 
Steger, M. Viard, M. Wimmer, in preparation). Ongoing 
studies  are  examining  the  interaction  of  PTPIP51  with 
CGI-99 in astrocytoma and the impact resulting from this 
interaction for malignant growth. 
In addit ion to this mitotic function , TPR-domain-containing 
proteins are involved in processes such as protein transport, 
neurotransmitter release, phosphate turnover and splicing 
(Blatch and Lässle 1999). Vesicle trafficking is functionally 
associated with coiled-coil proteins (Gillingham and Munro 
2003). PTPIP51 possesses such a coiled-coil domain. 
The transport and release of the neurohormones vaso- 
pressin and oxytocin are hallmarks of the function of the 
posterior p ituitary. Both hormones are produced in hypo- 
thalamic magnocellular neurons (Russel and Leng 2000). 
Expression studies in the mouse brain have shown PTPIP51 
to be expressed in hypothalamic magnocellular neurons with 
their fibres extending to the neurohypophysis. Furthermore, 
PTP IP5 1 is co-loc al ized  with the hormone vasopr essin and its 
carrier protein neurophysin II (Fotheringham et  al. 1991; 
Koch et al. 2009b). Here, PTPIP51 probably mediates 
vesicle transport and terminal release of the hormones by 
association with the microtubule transport system. 
PTPIP51 can also act as a signalling molecu le in a 
distinct signalling pathway. Interacting with Raf-1 mediated 
by proteins of the 14-3-3 family, PTPIP51 influences the 
 
Fig. 6  PTPIP51 has two bind- 
ing sites for 14-3-3 proteins, 
named conserved regions 1 and 
2 (CR1, CR2), each of which is 
capable of binding to 14-3-3. A 
transmembrane domain (TMD) 
is located in close proximity to 
the conserved regions of 
PTPIP51. These domains are 
surrounded by serine and tyro- 
sine phosphorylation sites. The 
serine residues aa46 and aa149 
are critical for 14-3-3 binding to 
PTPIP51. The tyrosine residues 
aa53 and aa158 are probable 
regulation sites inhibiting the 
interaction of PTPIP51 and 
14-3-3. a Localization of the 
TMD and the two conserved 
regions of PTPIP51. b Serine 
phosphorylation sites (red) and 
tyrosine phosphorylation sites 
(green) and their relationship to 
the conserved regions (PTPIP51 
full-length protein). c Serine 
phosphorylation sites (red) and 
tyrosine phosphorylation sites 
(green) and their relationship to 
the conserved regions (PTPIP51 
38-kDa isoform). d Tertiary 
structure of CR1 and its serine 
aa46 and tyrosine 53 residues. e 
Tertiary structure of CR2 and its 
serine aa149 and tyrosine aa158 
residues. f Tertiary structure of 
serine aa212 and tyrosine aa176 
residues 
  
Position Kinase Peptide Experimental data 
53 Abl SLPNSLDYTQTSDPG No 
158 Abl STGSSSVYFTASSGA No 
176 Abl DAESEGGYTTANAES No 
53 Abl2 SLPNSLDYTQTSDPG No 
53 EGFR SLPNSLDYTQTSDPG No 
158 EGFR STGSSSVYFTASSGA No 
176 EGFR DAESEGGYTTANAES No 
53 FGFR3 SLPNSLDYTQTSDPG No 
53 IGF1R SLPNSLDYTQTSDPG No 
158 IGF1R STGSSSVYFTASSGA No 
176 InsR DAESEGGYTTANAES No 
53 JAK1 SLPNSLDYTQTSDPG No 
176 JAK1 DAESEGGYTTANAES No 
53 JAK2 SLPNSLDYTQTSDPG No 
176 JAK2 DAESEGGYTTANAES No 
53 JAK3 SLPNSLDYTQTSDPG No 
158 Fyn STGSSSVYFTASSGA No 
176 Fyn DAESEGGYTTANAES No 
53 Yes SLPNSLDYTQTSDPG No 
300 Yes EVSEKKSYALDGKEE No 
158 HCK STGSSSVYFTASSGA No 
158 Lyn STGSSSVYFTASSGA Yes 
176 Lyn DAESEGGYTTANAES Yes 
158 Lck STGSSSVYFTASSGA No 
176 Lck DAESEGGYTTANAES No 
158 Src STGSSSVYFTASSGA Yes 
176 Src DAESEGGYTTANAES Yes 
158 BLK STGSSSVYFTASSGA No 
176 BLK DAESEGGYTTANAES No 
176 Brk DAESEGGYTTANAES No 
53 Syk SLPNSLDYTQTSDPG No 
176 Syk DAESEGGYTTANAES No 
53 ZAP70 SLPNSLDYTQTSDPG No 
158 ZAP70 STGSSSVYFTASSGA No 
176 ZAP70 DAESEGGYTTANAES No 
158 PDGFRa STGSSSVYFTASSGA No 
176 PDGFRa DAESEGGYTTANAES No 
158 KIT STGSSSVYFTASSGA Yes 
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activity of the MAPK pathway. The interactions with the 
14-3-3 proteins take place at  two  defined sites of PTPPI51. 
These sites, named conserved regions (CR) 1 and 2, span 
aas43 to 48 and aas 146 to 154. Notably, the p resence of 
only one conserved region is sufficient for binding to 14-3- 
3 with subsequent Raf-1 modulat ion (Jin et al. 2004;  Yu  et 
al. 2008). Figure 6a, d, e  illustrates the localization of the 
two conserved regions of the PTPIP51 protein. Two recent 
studies have added evidence that PTPIP51 is involved in 
the MAPK pathway (Bobrich et al. 2011; M. Petri, P. Koch, 
A. Stenzinger, K. Kuchelmeister, U. Nestler, K. Steger, M. 
Viard, M. Wimmer, in preparation). In  contrast, AML blasts 
display no interaction of PTPIP51 and Raf-1 (A. Brobeil, 
M. Bobrich, M. Graf, A. Kruchten, W. Blau, M. Rummel, 
S. Oeschger, K. Steger, M. Wimmer, in preparat ion). This 
may be attributable to the observed high phosphorylation 
status of PTPIP51 in AML blasts. PTP1B interacts with 
PTPIP51 in normal neutrophil granulocytes (Brobeil et al. 
2010). The interaction is abolished in AML b lasts leading 
to  the  high  phosphorylation status  of  PTPIP51. PTP1B 
 
 
Table 2  Tyrosine kinases phos- 
phorylating PTPIP51 (Abl V-abl 
Abelson murine leukemia viral 
oncogene homolog 1, Abl2 
Abelson-related gene protein, 
EGFR epidermal growth factor 
receptor, FGFR fibroblast 
growth factor receptor, IGF 
insulin-like growth factor 1 
receptor, InsR insulin receptor, 
JAK Janus kinase, Fyn proto- 
oncogene tyrosine protein, HCK 
haematopoietic cell kinase, Lyn 
Src-family tyrosine kinase, Lck 
lymphocyte-specific protein 
tyrosine kinase, Scr Rous sarco- 
ma nonreceptor tyrosine kinase, 
BLK B lymphocyte kinase, brk 
breast tumor kinase, Syk spleen 
tyrosine kinase, ZAP70 zeta- 
chain-associated protein kinase 
70, PDGFR platelet-derived 
growth factor receptor, KIT 
CD117) 
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function is double-edged in cancer. It  can act both as a 
tumour suppressor and as a tumour promoter dependent on 
the cancer type (Lessard et al. 2010). As shown in Fig. 6b, 
d-f, PTPIP51 possesses serine and tyrosine phosphorylation 
sites. The majority of kinases involved in their phosphor- 
ylation are still unknown. Serine residues 46 and 212 have 
been demonstrated to be phosphorylated during cell cycle 
progression and mitosis (Cantin et al. 2008; Daub et al. 
2008; Dephoure et al. 2008). Furthermore, PTPIP51 is 
phosphorylated by c-Src at the tyrosine 176 residue (A. 
Brobeil, M. Bobrich, M. Wimmer, in  preparat ion). In 
addition, A. Brobeil, M. Bobrich, M. Graf, A. Kruchten, 
W. Blau, M. Rummel, S. Oeschger, K. Steger, M. Wimmer 
(in  preparation) have identified Lyn, another member of the 
Src family kinases (SFK) and revealed that it  interacts with 
PTPIP51 in human  AML b lasts by phosphorylat ing 
tyrosine 176. Minor phosphorylations by SFK or other 
kinases have been observed for tyrosine residues 53 and 
158. The phosphorylation is reversed by the T-cell protein 
tyrosine phosphatase (Stenzinger et al. 2009b). Computa- 
tional predictions of PTPIP51-interacting  kinases for the 
phosphorylation at tyrosine residues 53, 158 and 176 and at 
serine residues 46, 149 and 212 are listed in Tables 2, 3. 
Strikingly, except for serine residue 212, the serine residues 
are located in the two conserved regions (Fig. 6b, S46 and 
S149). The serine residues aa46 and aa149 have to be 
phosphorylated and are critical for 14-3-3 binding (Yu et al. 
2008). Using the group-based prediction system 2.1 (GPS 
2.1; http://gps.biocuckoo.org/; Xue et  al. 2008), protein 
kinase C (PKC) has been ident ified to mediate the 
phosphorylation at the serine residues of CR1 and CR2. 
The two serine residues of the conserved regions are 
surrounded by two tyrosine residues, viz. aa53 and aa158. 
An additional protein domain is located in close proximity 
to the CR1, namely a TMD (Fig. 6b, d), which is part of the 
mitochondrial apoptotic system. Apoptosis is initiated by 
the localization of the PTPIP51 fu ll-length protein to the 
mitochondria (Lv et al. 2006). The 38-kDa isoform lacks 
this TMD and is therefore incapable o f inducing apoptosis 
(Lv et  al. 2006). Nevertheless, the CR2 is located at the 
truncated N-terminus of the 38-kDa isoform promoting 14- 
3-3 b inding with subsequent Raf-1 activ ity modulat ion (Yu 
et al. 2008; for a representation, see Fig. 6c). Bound 14-3-3 
protein caps this TMD structure (Fig. 6d). This capping 
could be a mechanism to prevent uncontrolled entry into 
apoptosis during the cell cycle. According to the phosphor- 
ylation atlas of mitotic proteins, PTPIP51 is phosphorylated 
at serine residues aa49 and aa212 (Dephoure et al. 2008). A 
similar regulatory mechanis m is well established for BAD, 
a pro-apoptotic protein of the Bcl-2 family. 14-3-3 proteins 
separate BAD from the mitochondrial membrane. More- 
over, BAD and PTPIP51 are both controlled by the same 
kinase p90RSK phosphorylating the critical serine residue 
46 in PTPIP51 (Tan et al. 2000; see Table 3). Figure 7 
illustrates the hypothetical involvement of PTPIP51 in 
signalling pathways maintaining cell survival. 
The c-Abl proto-oncoprotein is a  member of the Src 
family of non-recep tor ty rosine kinases. c-Abl is a 
ubiquitously expressed protein that localizes both to the 
nucleus and the cytoplasm where it  plays distinctly different 
roles (Shaul and Ben-Yehoyada 2005). Expression of c-Abl 
in the cytoplasm results in cell proliferat ion and survival. 
Cytoplasmic c-Abl is involved in the response to growth 
factor stimulation by promoting  DNA synthesis, F-act in 
assembly and receptor trafficking (Sirvent et al. 2008). In 
contrast, activated nuclear c-Abl induces apoptosis after 
genotoxic stress. The molecular mechanis ms that transport 
c-Abl to the nucleus have been studied by Yoshida (2007a). 
14-3-3 proteins sequester c-Abl in the cytosol of normal 
cells. Genotoxic stress leads to the phosphorylation of 14-3- 
 
Table 3  Serine/threonine 
kinases phosphorylating 
PTPIP51 (PK protein kinase, 
RSK ribosomal s6 kinase family, 
IPL1 Aurora protein kinase) 
 
Position Kinase Peptide Experimntal data 
 
46 PKA QRHGRSQSLPNSLDY No 
149 PKA FPFVRERSDSTGSSS No 
212 PKA VKMGRKDSLDLEEEA Yes 
46 PKC QRHGRSQSLPNSLDY No 
149 PKC FPFVRERSDSTGSSS No 
46 p70RSK QRHGRSQSLPNSLDY No 
149 p70RSK FPFVRERSDSTGSSS No 
212 p70RSK VKMGRKDSLDLEEEA No 
46 IPL1-yeast QRHGRSQSLPNSLDY No 
212 IPL1-yeast VKMGRKDSLDLEEEA No 
46 RSK1 QRHGRSQSLPNSLDY No 
149 RSK1 FPFVRERSDSTGSSS No 
212 RSK1 VKMGRKDSLDLEEEA No 
46 RSK2 QRHGRSQSLPNSLDY No 
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Fig. 7  Cell survival is mediated 
through distinct signalling path- 
ways, namely the mitogen- 
activated protein kinase 
(MAPK) pathway and protein 
kinase C (PKC) signalling. In 
both pathways, PTPIP51 can 
interact with 14-3-3 and thus 
modify the two pathways. A 
necessary prerequisite is the 
phosphorylation of PTPIP51 by 
PKC. This results in the inhibi- 
t ion of the translocation of 
PTPIP51 to the mitochondrial 
membrane and thus in the inhi- 
bition of apoptosis (pathway 
left). The star indicates the 
computational calculation of the 
interaction (CREB cAMP- 
response element binding pro- 
tein, ERK1/2, p90RSK, SOS, 
Grb2, Ras, Raf-1 members of 
the MAPK pathway). The dia- 
gram was created by using the 
Pathwaybuilder online tool at 
www.proteinlounge.com 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 by c-jun N-terminal kinase. Thus, c-Abl is able to  enter 
the nucleus and induce apoptosis (Yoshida 2007a). 
A possible downstream substrate of the c-Abl tyrosine 
kinase is PKCdelta. DNA damage is followed by the 
activation of c-Abl, which then phosphorylates PKCdelta, 
thereby  inducing  apoptosis  (Yoshida  2007b).  Not  only 
DNA damage but also endoplasmic reticu lum (ER) stress 
can be followed by apoptosis. ER stress leads to the 
interaction of PKCdelta and c-Abl. The PKCdelta-Abl 
complex conveys the apoptotic signal to the mitochondria 
(Qi and Mochly-Rosen 2008). Earlier studies by Lv et al. 
(2006) and Stenzinger et al. (2009b) have revealed that 
 
 
 
 
Fig. 8  Localization of PTPIP51 protein containing the N-terminus, 
sequence aas114-129 or the C-terminus in placenta. a The N-terminal- 
containing isoform of PTPIP51 is restricted to the syncytial knots 
(arrow )  and  endothelial  cells  lining  the  blood  vessels  (double 
arrow head). b  The  isoforms  of  PTPIP51  including  the  sequence 
aas114-129 are exclusively expressed in the cytot ro ph obl as t (ar row ).  c  
The syncytiotrophoblast reacted positively for the C-terminal se- 
quence of PTPIP51 (double arrow ). Bars 20 μm 
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PTPIP51 plays a pivotal role in apoptosis. GPS 2.1 (http:// 
gps.biocuckoo.org/) has shown PTPIP51 to be a substrate 
of c-Abl phoshorylating tyrosine residues 53 and 176. The 
close  proximity  of  serine  res idue  46  to  the  tyrosine 
residue 53 suggests that both have a regulatory function. 
Recent cell culture experiments have revealed that tyrosine 
phosphorylation is critical for the regulat ion of 14-3-3 
binding to  PTPIP51. In  HaCat cells, phosphatases have 
been blocked by exposing cells to pervanadate. As a 
consequence, tyrosine residues of PTPIP51 are hyper- 
phosphorylated. Subsequent interaction quantification has 
revealed a significant decrease of PTPIP51 and 14-3-3beta 
interaction. Therefore, we conclude that tyrosine phosphor- 
ylation is an important regulatory mechanism for 14-3-3 
binding to PTPIP51 (A. Brobeil, M. Bobrich, M. Wimmer, 
in preparation). The interact ion of Bcr with 14-3-3 proteins 
is comparably  regulated. The adaptor proteins 14-3-3 bind 
to specific  phosphoserine motifs of Bcr. Phosphorylation of 
tyrosine residues on Bcr inhibit  the binding of 14-3-3 
proteins. In consequence, their ability to form a complex 
with  Raf-1 is inhibited with respect to modulating Raf-1 
activity (Peters and Smithgall 1999). PTPIP51 also modu- 
lates  Raf-1  act ivity  through  14-3-3  adaptor  molecu les 
(Yu et al. 2008). This mechanis m is probably responsible 
for the c-Abl-induced dissociation of the 14-3-3 proteins 
from the CR1, rendering the TMD accessible and leading to 
protein translocation to the mitochondria and the induction 
of apoptosis. In addition, serine/threonine protein phospha- 
tases (PPs) such as PP1, PP2A and PP2B enable BAD to 
interact with Bcl-XL  and in itiate cell death (Klumpp and 
Krieglstein 2002). These protein phosphatases might also 
desphosphorylate PTPIP51 at  its serine 46 residue leading 
to the dissociation of the 14-3-3 proteins with subsequent 
apoptosis. By regulating the serine phosphorylation by 
PKC, the PTPIP51/14-3-3 complex p robably inhibits PKC 
activity, which is reflected in the alternative name of 14-3-3 
proteins, namely  kinase C inh ib itor p roteins. 14-3-3 
proteins have a mot if exhib iting similarity to the pseudo- 
substrate site on PKC and might inhibit  kinase activity by 
blocking the active site (Robinson et al. 1994). 
The important functions of PTPIP51 are reflected by its 
expression in many different tissues with diverse subcellu- 
lar localizations, probably determined by its local function. 
Brobeil and co-workers (2010) have used peptide-specific 
antibodies to detect sequences of PTPIP51 comprising the 
C-terminus, N-terminus and an amino acid sequence 
spanning aa114 to 129. The subcellular distributions of 
PTPIP51 isoforms are  given for  the  human  placenta in 
Fig. 8. The human placenta exhibits an isoform-specific 
localizat ion of PTPIP51 (Fig . 8a-c). The N-terminal 
containing PTPIP51 is restricted to a s mall subset of 
syncytioth rophob last  cells  lin ing  the  syncyt ial  knots 
(Fig. 8a, arrow). Endothelial cells also express PTPIP51 
containing this peptide sequence (Fig. 8a, double arrow- 
head). All other cells remain  negative for the N-terminal 
peptide sequence (Fig. 8a). Only the cytotrophoblast stains 
positively for the PTPIP51 including  aas114-129 (Fig. 8b, 
arrowhead). A ll cells of the syncytiotrophoblast express 
PTPIP51 isoforms that include the C-terminal sequence 
(Fig. 8c, double arrow). 
As PTPIP51 takes part in many cellular p rocesses, it is 
present in almost every cell compartment. The leaky 
scanning mechanis m prov ides an effective tool to generate 
mult iple isoforms  delivered to d ifferent compartments 
(Kochetov 2008). For example, use of the second AUG 
triplet within the main ORF results in the lack o f the N- 
terminal-located mitochondrial target sequence and, there- 
fore, the protein cannot be translocated to the mitochondria. 
 
 
Concluding  remarks 
 
PTPIP51 is a multifunctional protein with an important 
impact on major cellular functions such as proliferat ion, 
di ffe re nt iat ion and apoptosis, thereby being a real function- 
al jack–of-all-trades protein. The strict regulation of the 
PTPIP51 gene and its mRNA indicates that PTPIP51 is 
probably a potent oncogene, the dysregulation of which 
might result in the onset of cancer. Further studies are 
needed to reveal the detailed functions of PTPIP51 in the 
integration of distinct signalling networks. 
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35 Abstract 
 
36 Aims:  Our  previous  experiments  revealed  an  association  of  PTPIP51  (Protein 
 
37 Tyrosine  Phosphatase  interacting  protein  51)  with  the  insulin  signalling  pathway 
 
38 through PTP1B and 14-3-3beta. We aimed to clarify the role of PTPIP51 in adipocyte 
 
39 metabolism. 
 
 
40 Methods: Four groups of ten black six mice each were used. Two groups were fed a 
 
41 standard diet; two groups were fed a high fat diet. After four weeks of adaptation, two 
 
42 groups  (one  high  fat diet  and  one  standard diet)  were  submitted  to  endurance 
 
43 training, while the remaining two groups served as untrained control groups. After ten 
 
44 weeks, we measured the insulin resistance of every mouse using a glucose tolerance 
 
45 test. Adipose tissue samples were analyzed by immunofluorescence and Duolink 
 
46 proximity ligation assay to verify and quantify interactions of PTPIP51 with either 
 
47 insulin receptor (IR) or cAMP activated protein kinase A (PKA). 
 
 
48 Results:  PTPIP51  and  the  IR  respectively  PKA  were  colocalized  in  all  groups. 
 
49 Standard  diet  animals  that  were  submitted  to  endurance  training  showed  low 
 
50 PTPIP51-IR- and PTPIP51-PKA-interaction. The interaction levels of both the IR and 
 
51 PKA were associated to the grade of insulin sensitivity, feeding and training status of 
 
52 the animals. 
 
 
53 Conclusion: PTPIP51 might serve as a linking protein in adipocyte metabolism by 
 
54 connecting the IR-triggered lipogenesis with the PKA-dependent lipolysis. PTPIP51 
 
55 interacts with both proteins, therefore being a potential gateway for the cooperation 
 
56 of both pathways. 
 
 
57 
 
58 
3 
59 
60 
 
 
 
61 
 
62 
 
63 
 
64 
 
65 
 
66 
 
67 
 
68 
 
69 
 
70 
 
71 
 
72 
 
73 
 
74 Keywords 
 
75 Diabetes, Obesity, insulin resistance, adipocyte 
 
76 
 
77 
 
78 
 
79 Abbreviations 
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Introduction 85 
86 
 
 
 
87 Obesity abets several life style diseases such as diabetes type II, atherosclerosis or 
 
88 impaired wound healing. These adverse effects can be avoided or, if already present, 
 
89 reduced  by physical  activity. Physical  activity increases  sympathetic  activity and 
 
90 blood catecholamine levels. Adaption to periodic physical exercise is well-studied. 
 
91 Exercise training and increased catecholamine levels affect adipocyte metabolism, 
 
92 on  the one hand  by influencing  insulin  secretion  [1] and on the  other hand  by 
 
93 additionally channelling the adipocyte metabolism towards lipolysis [2]. This effect is 
 
94 mediated by beta2-adrenergic receptors which activate the intracellular  adenylyl- 
 
95 cyclase. Adenylyl-cyclase transforms ATP into cyclic AMP (cAMP), which in turn 
 
96 increases the activity level of cAMP dependent protein kinase A (PKA) [3, 4]. Protein 
 
97 kinase A thereupon initiates lipolysis [4]. 
 
98 The most potent antagonist of catecholamines on adipose tissue is insulin. Activation 
 
99 of  the  insulin  receptor  results  in  decreased  lipolysis,  increased  lipogenesis  and 
 
100 uptake of fatty acids. 
 
101 Lipolysis is decreased by insulin receptor induced phosphodiesterase-3B (PDE-3B) 
 
102 and 14-3-3beta dependent reduction of PKA activity [3, 5]. Furthermore, the insulin 
 
103 receptor  activates  several  lipogenic  enzymes  by  tyrosine  phosphorylation  and 
 
104 promotes GLUT-4 recruitment to the cell membrane [6]. 
 
105 Protein  Tyrosine  Phosphatase  Interacting  Protein  51  (PTPIP51) is  expressed  in 
 
106 different organs with a multitude of functions [7, 8]. As previously shown for mouse 
 
107 adipose tissue, PTPIP51 acts as an effector in insulin signalling. PTPIP51 expression 
 
108 was  correlated  to  the  insulin  resistance  of  the  animals  [9],  according  to  the 
 
109 expression of its interaction partner Protein Tyrosine Phosphatase 1B (PTP1B). In 
 
110 addition  to  that,  PTPIP51  is  connected  to  the  lipolytic  MAPK  pathway  by  its 
interaction  with  raf-1 mediated  by  14-3-3beta  [7].  14-3-3beta  also  interacts  with 111 
5 
 
 
 
112 phosphodiesterase 3B, resulting in reduced intracellular cAMP levels and decreased 
 
113 PKA activity [9]. As 14-3-3beta and PTP1B are important for adipocyte metabolism 
 
114 control, the role of its interaction partner PTPIP51 needs to be disclosed. 
 
115 The interaction of PTPIP51 with the insulin receptor and PKA was investigated in 
 
116 adipose tissue from animals kept under different defined experimental conditions to 
 
117 
 
118 
 
119 
 
120 
 
121 
 
122 
 
123 
 
124 
 
125 
 
126 
 
127 
 
128 
 
129 
 
130 
 
131 
 
132 
 
133 
 
134 
 
135 
 
136 
clarify the role of PTPIP51 in adipocyte metabolism. 
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137 
 
138 
Material and Methods 
 
139 Study design 
 
140 The experiments were performed with male Bl6 mice (n=40) and approved by the 
 
141 local Animal Care and Use Committee (Gi 20/24 Nr.94/2010). The animals were kept 
 
142 under standard conditions (12 hr light / dark cycle) with no access to running wheels. 
 
143 They were fed ad libitum with free access to water. The animals were aged ten 
 
144 weeks at the beginning of the training. The experiments were run for 14 weeks, with 
 
145 a four week period of fat feeding followed by a ten week training period. 
 
146 Control group (SD): The animals were fed a standard diet (Altromin standard-diet 
 
147 #1324, Altromin, Lage, Germany). 
 
148 Endurance  training  control  group  (SDT):  The  animals  were  fed  a  standard  diet 
 
149 (Altromin standard-diet #1324, Altromin, Lage, Germany) and trained for a period of 
 
150 ten weeks. The endurance training was performed on a motorized treadmill for 35 
 
151 min/day at 12 m/min, at 12 % grade, 5 times per week, for ten weeks. Running speed 
 
152 was 0.27 m/s ± 0.05 m/s corresponding to 80 % of maximal oxygen consumption. 
 
153 High-fat-diet group (HFD): The animals were fed a high-fat-diet containing 45% fat for 
 
154 14 weeks of the experimental period. 
 
155 High-fat-diet, training group (HFDT): The animals were fed a high-fat-diet during the 
 
156 complete experimental time period. The endurance training period started four weeks 
 
157 after the beginning of high fat diet feeding. The endurance training was performed on 
 
158 a motorized treadmill for 35 min/day at 12 m/min, at 12 % grade, five times per week, 
 
159 for ten weeks. Running speed was 0.27 m/s ± 0.05 m/s corresponding to 80 % of 
 
160 maximal oxygen consumption. 
 
161 For diet composition see table 1, for mean body weights see table 2. 
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Values in kcal/100g Standard diet High fat diet 
Protein 24 20 
Carbohydrates 65 35 
Fat 11 45 
162 
 
163 
Table 1: Energy content of standard diet and high fat diet. 
 
 Basic value (10 
 
weeks of age) 
Beginning of 
 
training (14 weeks 
of age) 
End of test period 
 
(24 weeks of age) 
Normal diet (ND) 23.22+- 2.41 23.16 ± 1.03 27.74 ± 0.96 
Normal diet and 
 
training (NDT) 
22.81+- 3.11 22.79 ± 0.77 26.54 ± 1.15 
High fat diet (HFD) 23.67+- 3.02 40.37 ± 2.97 50.91 ± 2.56 
High fat diet and 
 
training (HFDT) 
23.44+-2.88 42.22 ± 3.18 49.23 ± 3.43 
164 
 
165 
Table 2: Mean body weight in grams with standard deviation. 
 
166 After 14 weeks the animals were sacrificed in the morning between 10 and 12 o’clock 
 
167 and the abdominal adipose tissue was frozen in liquid nitrogen precooled isopentan 
 
168 and transferred to -80°C till further analysis. See also Bobrich et al. [9]. A glucose 
 
169 tolerance test was performed to determine the Insulin sensitivity of the mice [9, 10, 
 
170 11]. For testing the glucose tolerance of the animals they were injected 
 
171 intraperitoneally with 2g of 20% D-Glucose glucose dissolved in sterile 0.9% NaCl 
 
172 solution per kg body weight. The blood was collected and glucose concentration was 
8 
 
 
173 determined. The test was performed in the morning; last feeding of the animals took 
 
174 
 
175 
place the previous day. 
 
176 PTPIP51 Antibody production 
 
177 An  antibody against  a  defined peptide  sequence  at the  C-terminus of  PTPIP51 
 
178 (sequence: IQKDLEELEVILRD, exon 13) was produced (BioLux, Stuttgart, 
 
179 Germany). Identity and purity of the synthesized peptide were approved by ESI-MS 
 
180 and UV-analysis. Rabbits were immunized with the KLH-conjugated peptide. The 
 
181 specificity of the antibody was tested by ELISA and Western blot. Preabsorption 
 
182 
 
183 
experiments were performed [9, 12]. 
 
184 Immunofluorescence 
 
185 Immunofluorescence staining was performed according to a standard protocol [9]. 
 
186 The primary PTPIP51 antibody to the C-Terminus was used in 1:800 dilutions and 
 
187 visualized by Alexa 555 (Molecular Probes, Darmstadt, Germany, Cat.-# A21428). 
 
188 Primary monoclonal mouse antibodies were used for double staining experiments 
 
189 with PKA (ab58187, Abcam plc, 330 Cambridge Science Park, Cambridge, CB4 0FL) 
 
190 and  the beta-subunit of  the IR  (clone  CT-3,  Millipore,  28820 Single  Oak Drive, 
 
191 Temecula, CA 92590). To avoid unspecific binding of the primary mouse antibodies, 
 
192 samples were preincubated with biotin-coupled anti-mouse-antibodies for one hour. 
 
193 The reaction of the primary monoclonal mouse antibody was visualized using Alexa 
 
194 fluor  488  secondary  antibodies  (Molecular  Probes,  Darmstadt,  Germany,  Cat.-# 
 
195 
 
196 
A11001). 
 
197 Confocal laser scanning microscopy 
9 
 
 
198 Confocal  images  of  cells  were  obtained  with  a  Leica  confocal  laser  scanning 
 
199 microscope (CLSM, 5 TCS SP2, Leica, Bensheim, Germany). Confocal images of 
 
200 Alexa Fluor 555 fluorescence were acquired using 6 Plan-Apochromat ×40/1.4 oil 
 
201 objective, 548 nm excitation wavelengths (helium-neon laser) and a 560–585 nm 
 
202 band-pass filter. The pinhole diameter was set to yield optical sections of 1 Airy unit. 
 
203 For  the  detection  of  Alexa  Fluor  488,  we  used  a  Plan-Apochromat  ×40/1.4  oil 
 
204 objective, the 488 nm excitation wavelength of an argon laser, and a 505–530 nm 
 
205 band-pass filter. The pinhole diameter was set to yield optical sections of 1 Airy unit. 
 
206 Confocal images of To-Pro-3 fluorescence (Molecular probes, Cat.# T3605) (nuclear 
 
207 staining)  were  acquired  using  Plan-Apochromat  ×40/1.4  oil  objective,  633  nm 
 
208 excitation wavelengths (helium-neon laser), the 650–670 nm bandpass filter. The 
 
209 pinhole diameter was set to yield optical sections of 1 Airy unit. Acquired DIC and 
 
210 confocal  images  were  analyzed  and  combined  using  the  LCS  software  (Leica 
 
211 Confocal Software). 
 
212 Acquired images were subsequently processed by ImageJ (v1.43m; Rasband, W.S., 
 
213 ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
 
214 http://imagej.nih.gov/ij/, 1997-2011) using an iterative deconvolution plug-in by Bob 
 
215 Dougherty  (http://www.optinav.com/imagej.html,  Iterative  Deconvolution).  Options 
 
216 were set for all confocal acquired images as follows: 8 numbers of iteration and 2.0 
 
217 pixels of LP filter diameter. Point spread function was calculated for each channel 
 
218 separately by the ImageJ plug-in created by Bob Dougherty 
 
219 
 
 
220 
(http://www.optinav.com/imagej.html, Diffraction Limit PSF). 
 
221 Intensity correlation analysis 
10 
 
 
222 Intensity correlation analysis (ICA) was carried out using ImageJ (v1.43m; Rasband, 
 
223 W.S.,  ImageJ,  U.  S.  National  Institutes  of  Health,  Bethesda,  Maryland,  USA, 
 
224 http://imagej.nih.gov/ij/, 1997-2011) and an appropriate plug-in for ICA included in the 
 
225 plug-in package of the Wright cell imaging facility [13] 
 
226 
 
 
227 
(http://www.uhnres.utoronto.ca/faci lities/wcif/fdownload.html). 
 
228 Duolink proximity ligation assay (DPLA) 
 
229 Interaction of PTPIP51 with either PKA or beta-subunit of the IR was detected by the 
 
230 proximity ligation assay kit DuoLink (Olink biosciences, Uppsala, Sweden, PLA probe 
 
231 anti-rabbit minus for the detection of the rabbit PTPIP51 antibody, Cat.# 90602; PLA 
 
232 probe anti-mouse plus for the detection of the mouse anti PKA or IR antibody, Cat.# 
 
233 90701; Detection Kit 563, Cat.# 90134). 
 
234 The DPLA was performed according to the manufacturer’s protocol; negative controls 
 
235 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
236 
 
237 
were included [9, 14, 15]. For principle of the DPLA see figure 1. 
 
 Figure 1 
 
238 Fluorescence microscopy 
 
239 The Axioplan 2 fluorescence microscope equipped with Plan-Apochromat objectives 
 
240 (Carl Zeiss Jena, Germany) was used for photo documentation. For visualization of 
11 
 
 
241 the DPLA an excitation filter with a spectrum of 530-560nm and an emission filter 
 
242 
 
243 
with a spectrum of 572-647nm were used. 
 
244 Analysis of Duolink proximity ligation assay results 
 
245 The  Duolink  Image  Tool  (Olink  biosciences,  Uppsala,  Sweden)  was  used  for 
 
246 quantification of the detected DPLA signals. All analyzed sections were investigated 
 
247 with equal light intensity and shutter speed. Sensitivity of the software scan and blob 
 
248 threshold were set identically for all probes. The positive reaction dots were counted 
 
249 
 
250 
automatically. 
 
 
251 Database research 
 
 
252 We accomplished a database research using the GPS 2.1 database [16] to identify 
 
253 kinases  within  adipocyte  metabolism  that  possess  the  ability  to  phosphorylate 
 
254 
 
 
255 
 
 
256 
 
 
257 
 
 
258 
 
 
259 
 
 
260 
 
 
261 
 
 
262 
PTPIP51. 
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263 
 
264 
Results 
 
265 Glucose tolerance test 
 
266 The glucose tolerance was determined by a standard glucose tolerance test at the 
 
267 end of the experimental period. SD and SDT animals displayed a slight increase of 
 
268 blood  glucose  levels  30  minutes  after  application  of  glucose  which  was  almost 
 
269 normalized after 60 minutes. 
 
270 In HFD animals, blood glucose levels strongly increased from the basal level of 
 
271 1mg/dl to 4 mg/dl 60 minutes after application. Blood glucose levels did not return to 
 
272 normal values within 120 minutes. 
 
273 In HFDT animals, blood glucose levels increased to 2.7 mg/dl 30 minutes after 
 
274 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
275 
 
276 
application and almost returned to normal values after 120 minutes (Fig. 2). 
 
 Figure 2 
 
277 PTPIP51 protein is colocalized with the insulin receptor (IR) and protein kinase A 
 
278 (PKA) 
 
279 PTPIP51 localization in adipose tissue did not differ between the four experimental 
 
280 set ups. PTPIP51 immunoreactivity was detected within the cytoplasm and at the 
 
281 plasma membrane (Fig. 3). 
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282 The IR revealed a similar expression pattern when compared to PTPIP51. In the 
 
283 cytoplasm, the immune reaction of the IR antibody was lower compared to PTPIP51. 
 
284 The computed data of the intensity correlation analysis is displayed in figure 3B. Co- 
 
285 localization is displayed in yellow to orange and non-co-localized parts are shown in 
 
286 blue. Most colocalization was detected at the plasma membrane. 
 
 
287 PKA is also co-localized with PTPIP51, especially concerning its expression in the 
 
288 cytoplasm. The computed data of the intensity correlation analysis is displayed in 
 
289 figure 3D. Co-localization is displayed in yellow to orange and non-co-localized parts 
 
290 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
291 
 
292 
are  shown  in  blue.  Most  colocalization  was  detected  within  the  cytoplasm. 
 
 Figure 3 
 
293 PTPIP51 and IR interact and the interaction depends on the feeding status 
 
294 The Duolink proximity ligation assay (DPLA) was performed to detect interactions 
 
295 between PTPIP51 and the beta-subunit of the IR. The interaction of PTPIP51 and IR 
 
296 was verified as seen in figure 4, where each dot indicates the interaction of both 
 
297 proteins. This interaction of PTPIP51 and the IR was found in adipocytes of animals 
 
298 from all experimental groups. Specifity of the DPLA was tested (Fig. 4). 
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299 Figure 4 
 
300 The grade of interaction in adipose samples from SD animals corresponds to the 
 
301 level in HFDT animals. A decrease in the interaction was detected in samples from 
 
302 
 
303 
SDT animals. HFD animals displayed the highest interaction level (Fig. 5A). 
 
304 Interaction between PTPIP51 and PKA displayed a dependency on training status 
 
305 The Duolink proximity ligation assay was performed to detect interactions between 
 
306 PTPIP51 and PKA. The assumption of an interaction of PTPIP51 and PKA based on 
 
307 the database research was verified (Fig. 4). PTPIP51 and PKA were interacting in 
 
308 adipocytes of animals from all experimental groups. 
 
309 The  Interaction  levels  of  SD,  HFD  and  HFDT  mice  did  not  show  significant 
 
310 
 
 
 
 
 
 
 
 
 
 
311 
 
 
312 
 
 
313 
differences. The interaction levels seen in SDT mice were decreased (Fig. 5B). 
 Figure 5 
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314 Discussion 
 
 
315 To sum up the results, adipocytes from mice subjected to different diets and activity 
 
316 levels displayed a connection between PTPIP51 and the insulin receptor respectively 
 
317 PKA. Animals of the four experimental groups displayed differences in their glucose 
 
318 resistance. The glucose tolerance test revealed a glucose intolerant status in HFD 
 
319 and  HFDT  animals,  whereas  the  glucose  tolerance  of  HFDT  animals  improved 
 
320 compared to HFD animals. 
 
 
321 Immunofluorescence data displayed  colocalization  of  PTPIP51 with IR  and  PKA 
 
322 suggesting an interaction between PTPIP51 and IR respectively PKA. Basing on 
 
323 these facts, we performed a GPS 2.1 database research. Search results displayed 
 
324 PTPIP51 to be phosphorylated at tyrosine 176 by the insulin receptor and at serine 
 
325 46 by PKA [16]. These two phosphorylation sites are possible regulatory sites for the 
 
326 interaction  of  PTPIP51 with 14-3-3beta, thus  being  able  to  influence  the  MAPK 
 
327 pathway by interaction with raf-1 [17]. Phosphorylation of Serine 46 in PTPIP51 
 
328 results in augmented interaction with raf-1 via 14-3-3 and thus in increased ERK1/2 
 
329 phosphorylation,  promoting  the  MAPK pathway  [12, 17]. The  MAPK pathway  is 
 
330 suspected  to  possess  two  opposite  functions  in  adipocytes.  Depending  on  the 
 
331 activator, ERK1/2 conveys either adipocyte growth or lipolysis [18]. PKA is known to 
 
332 induce lipolysis through the MAPK pathway [18, 19]. 
 
 
333 The insulin receptor induces tyrosine phosphorylation of PTPIP51 at tyrosine 176, 
 
334 which  leads  to  reduced  interaction  of  PTPIP51  with  14-3-3beta  and  raf-1  [20], 
 
335 thereby decreasing the MAPK pathway activity. 
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336 Analysis of the PTPIP51 interaction profile of adipocytes displayed high interaction 
 
337 levels with the insulin receptor in HFD animals. Interaction levels were reduced by 
 
338 30% in SD and HFDT and by 50% in SDT animals, compared to HFD animals. 
 
 
339 High fat feeding increases the lipogenic activity in adipose tissue [21, 22]. This is 
 
340 consistent with our observation of high interaction levels in HFD animals. Training 
 
341 leads to reduced adipocyte size [23]. The reduced PTPIP51-IR interaction in trained 
 
342 groups compared to the corresponding untrained groups suggests that PTPIP51 is 
 
343 especially involved in processes of insulin induced lipogenesis or in its antilipolytic 
 
344 action. 
 
 
345 Interaction levels between PTPIP51 and PKA did not show significant differences in 
 
346 SD, HFD and HFDT animals. In NDT animals, interaction was reduced. 
 
 
347 The low interaction in NDT animals seems to be controversial. But, as PKA is known 
 
348 to also interact with hormone-sensitive lipase (HSL), a change of the interaction 
 
349 partner of PKA away from PTPIP51 under these preconditions is assumable. The 
 
350 interaction between PKA and HSL is a potent promoter for lipolysis in adipocytes. 
 
351 The activity of both PKA and HSL are increased in endurance trained animals [24, 
 
352 25]. 
 
 
353 Our  experiments  show  that  PTPIP51  could  mediate  between  lipogenesis  and 
 
354 lipolysis by switching between the lipogenic insulin pathway and the lipolytic PKA 
 
355 pathway.  Further  experiments  need  to  be  conducted  in  order  to  determine  the 
 
356 
 
 
357 
 
 
358 
magnitude in which PTPIP51 engages in adipocyte metabolism. 
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Figure legends 487 
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488 
 
489 Fig  1:  Principle  of  the  Duolink  Proximity  Ligation  Assay.  A)  Binding  of  primary 
 
490 antibodies to PTPIP51 and the IR, resp. PKA; B) Binding of secondary antibodies, 
 
491 PLA probe PLUS and PLA probe MINUS; C) Connector oligos only hibridize if both 
 
492 proteins are closer than 40nm; D) Ligation of the complex forms a circular template; 
 
493 E) Rolling circle amplification; F) Amplification yields a some hundred-fold replication, 
 
494 added fluorophore labelled probes highlight the reaction, resulting in a point-shaped 
 
495 
 
496 
 
497 
signal. 
 
498 Fig 2: Glucose tolerance test: Average of blood glucose concentrations in mg/dl after 
 
499 intraperitoneal application of glucose solution. Blood glucose levels were determined 
 
500 0, 30, 60 and 120 minutes after application. Glucose tolerance is inversely related to 
 
501 Insulin resistance. 
 
502 SD standard diet group (n=10), SDT standard diet and training group (n=10), HFD 
 
503 
 
504 
 
505 
high fat diet group (n=10), HFDT high fat diet and training group (n=10). 
 
506 Fig 3: Immunostaining of PTPIP51, insulin receptor and PKA in adipocytes of normal 
 
507 controls. 
 
508 A) Immunostaining of PTPIP51 and the insulin receptor; B) Intensity correlation of 
 
509 PTPIP51  and  the  insulin  receptor,  high  correlation  is  displayed  in  yellow;  C) 
 
510 Immunostaining of PTPIP51 and PKA; D) Intensity correlation of PTPIP51 and the 
 
511 
 
512 
insulin receptor, high correlation is displayed in yellow; Bar (A): 60μm; Bar (C): 15μm 
23 
 
 
513 
 
514 Fig 4: Duolink proximity ligation assay to detect interactions between PTPIP51 and 
 
515 the insulin receptor (IR) resp. PKA 
 
516 A) Interaction between PTPIP51 and the IR; B) Interaction between PTPIP51 and 
 
517 PKA; C) Negative control, PTPIP51 and the IR in testis, no interaction known; D) 
 
518 Negative control, DPLA without primary antibodies in adipose tissue; Nuclei are 
 
519 marked by DAPI staining; Arrows: positive reactions; Bars (A, B): 50μm; Bars (C, D): 
 
520 
 
521 
 
522 
20μm 
 
523 Fig  5:  Semiquantitative  analysis  of  the  interaction  between  PTPIP51  and  its 
 
524 interaction with IR and with PKA. 
 
525 Every  section  was  subdivided  into  rectangles  of  the  same  size  and  dots  were 
 
526 counted. The results were averaged for each section. 
 
527 A) Semiquantitative evaluation of PTPIP51 interaction with IR; 
 
528 B) Semiquantitative evaluation of PTPIP51 interaction with PKA. 
 
529 SD: standard diet group; SDT: standard diet and training group; HFD: high fat diet 
 
530 
 
531 
 
532 
group; HFDT: high fat diet and training group. 
